On October 23, 2026, C3.ai Inc AI shares rose 3.6% to $12.46. This increase is part of a broader trend where the stock has gained 10.1% over the past week and 14.7% over the past month. However, year-to-date, the stock is down 7.6%, and it has decreased 30.6% over the past year, fluctuating between a 52-week high of $18.64 and a low of $7.68.
GF Value™ verdict: Current price of $12.46 vs GF Value of $13.41, indicating a 7.1% undervaluation. GF Score™ is 61/100, which suggests an above-average rating. Most notable signal: Insider activity shows net selling of $75.4M over the past 12 months. Is AI Overvalued or Undervalued? C3.ai Inc currently trades at $12.46, which is below the GF Value™ estimate of $13.41. This suggests that the stock is undervalued by approximately 7.1%. The GF Valuation label indicates that the stock is fairly valued, although this assessment should be taken cautiously given the company's unprofitable status. The GF Value™ is an intrinsic value estimate derived from historical trading multiples, business growth, and future performance projections, providing a directional guide rather than a precise fair value for loss-making companies.
The margin of safety at this price raises some opportunities for investors, however, potential buyers should be aware of the inherent risks associated with investing in a cash-flow-negative entity. The lack of profitability can lead to volatile stock performance, and the company’s financial health needs to be carefully monitored.
How Does AI's Valuation Compare to Its History? Due to the unavailability of Price-to-Earnings (P/E) data for C3.ai, we cannot perform a direct comparison of its current valuation against its historical P/E metrics. Instead, we focus on the Price-to-Sales (P/S) ratio, which is more relevant for unprofitable companies. The historical median P/S ratio for C3.ai is approximately 9.2x. Current valuation metrics do not indicate an alignment with historical averages, but specific P/S data is required for a deeper analysis.
What Does AI's GF Score™ Tell Us? The GF Score™ is a comprehensive measure that evaluates a stock's investment potential based on various factors, including financial strength, profitability, growth, valuation, and momentum. C3.ai's GF Score™ is 61/100, indicating a performance that is above average relative to its peers.
Metric Rating GF Score™ 61 Financial Strength 8/10 Profitability 1/10 Growth 2/10 Valuation 9/10 Momentum 7/10 C3.ai shows strong financial strength with a rating of 8/10, suggesting robust financial health. However, its profitability rank is significantly low at 1/10, indicating challenges in generating profits. The valuation rank of 9/10 supports the notion that the stock may be undervalued, while a momentum rank of 7/10 reflects recent positive price action.
What Are Gurus and Insiders Doing with AI? C3.ai is currently held by four gurus, with two increasing their positions and two reducing their stakes in recent quarters. This mixed activity signals a cautious sentiment among institutional investors. Moreover, insider activity reveals that over the past year, insiders purchased $0.3M worth of shares but sold a substantial $75.7M, resulting in a net selling of $75.4M. Such a pattern of insider selling may raise concerns about the company's future prospects and should be taken into account by potential investors.
What This Means for Investors Based on the GF Value™ analysis, C3.ai Inc appears to be undervalued at its current price of $12.46. However, investors should proceed with caution due to the company's lack of profitability and the notable insider selling activity. This valuation assessment suggests that while there is potential for upside, the risks inherent to the stock must be thoroughly evaluated.
For more detailed information, visit the C3.ai Inc AI stock page to explore further insights and metrics.
Frequently Asked Questions What is AI's GF Score™?
The GF Score™ for C3.ai is 61/100, indicating that it has an above-average investment potential compared to its peers based on various fundamental factors.
Is AI overvalued or undervalued?
According to the GF Value™ analysis, C3.ai is currently undervalued with a price of $12.46 compared to a GF Value of $13.41, representing a margin of 7.1%.
What is AI's P/E ratio?
Currently, C3.ai does not have an available P/E ratio due to its unprofitable status, making a P/E comparison with historical data impractical.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
C3.ai, Inc. (AI - Free Report) closed at $12.03 in the latest trading session, marking a +2.04% move from the prior day. This change outpaced the S&P 500's 1.21% loss on the day. Elsewhere, the Dow saw an upswing of 0.02%, while the tech-heavy Nasdaq depreciated by 2.6%.
Prior to today's trading, shares of the company had gained 8.56% outpaced the Computer and Technology sector's loss of 3.87% and the S&P 500's loss of 0.03%.
Analysts and investors alike will be keeping a close eye on the performance of C3.ai, Inc. in its upcoming earnings disclosure. On that day, C3.ai, Inc. is projected to report earnings of -$0.22 per share, which would represent year-over-year growth of 12%. Meanwhile, our latest consensus estimate is calling for revenue of $53.09 million, down 29.36% from the prior-year quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$0.76 per share and a revenue of $223.01 million, representing changes of +43.7% and -10.89%, respectively, from the prior year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for C3.ai, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.12% upward. At present, C3.ai, Inc. boasts a Zacks Rank of #3 (Hold).
The Computers - IT Services industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 99, positioning it in the top 41% of all 250+ industries.
The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
HPE today announced HPE Spaceborne Computer-4, an advanced compute module built for space environments, plans to power artificial intelligence (AI) and the first high performance computing (HPC) benchmarks on the surface of the Moon1. The system will deploy on Astrolab’s FLIP rover for an upcoming mission for the Moon Base program and will test the suitability of advanced computing for future missions and the emerging lunar economy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261020987784/en/
HPE Spaceborne Computer-4, an advanced compute module built for space environments, plans to power artificial intelligence (AI) and the first high performance computing (HPC) benchmarks on the surface of the Moon.
“For more than 70 years, HPE innovation has supported some of the world’s most important space missions. The next chapter of lunar exploration will depend on the ability to turn data into insights at the point of discovery,” said Scott Wiest, vice president, fellow and global sales chief technologist, HPE. “With HPE Spaceborne Computer-4, we are bringing AI and high performance computing to the lunar edge, helping the acceleration of scientific discovery and building the infrastructure for the next era of exploration.”
The mission is intended to launch in late 2026 as part of NASA’s Commercial Lunar Payload Services (CLPS) initiative. After touching down near the lunar South Pole region, Voyager Technologies’ Griffin-1 lander will transport Astrolab’s FLIP rover, carrying HPE Spaceborne Computer-4 as a payload.
“The Moon presents a challenging environment for advanced computing, and we’re pleased to provide HPE with an opportunity to demonstrate its technology on the lunar surface,” said Jaret Matthews, founder and CEO of Astrolab. “Our FLIP rover is designed to accommodate a variety of payloads, and this mission will demonstrate how commercial lunar mobility platforms can support technology development and scientific research.”
AI workloads and first-ever HPC to run on the Moon’s surface
During the mission, HPE Spaceborne Computer-4 is scheduled to run core AI applications and the first high performance computing2 benchmarks on the Moon. The test results from these experiments will help create the technological foundation required for future missions and research on the Moon’s surface. Large language models (LLM) will deliver insights, analyze visual data, and support autonomous monitoring at the lunar edge. Additional tests will process LiDAR data for mapping, navigation, terrain analysis and infrastructure development, while an AI services container will demonstrate reliable deployment of scalable AI service applications on the Moon.
HPE Spaceborne Computer-4 is purpose-built as a lightweight, self-contained, and fanless compute module designed to survive the harsh environment of the lunar South pole. It is equipped with both a low-power central process unit (CPU) and graphics processing unit (GPU). The compute module utilizes flash memory storage inside solid state drives from KIOXIA, continuing a long-standing collaboration with the HPE Spaceborne program to support the missions’ activities and tests with high performance data storage under lunar conditions. HPE also assembled an extensive software suite that optimizes the required interaction with Earth-based resources and enables secure delivery of insights and results from the Moon back to Earth.
In addition, HPE will support Astrolab’s mission control in Hawthorne, California using HPE Private Cloud to support real-time insights, delivered in a turnkey solution. In addition, HPE CloudOps Software will provide a unified, flexible environment for managing and automating workloads.
Private-public partnerships help maximize the mission’s scientific return
NASA and Deloitte are set to join HPE Spaceborne Computer-4 to deploy AI workloads on the Moon and perform advanced solutions critical for maximizing the scientific return, underpinning the success of the emerging lunar economy.
Utilizing the Federated Learning for Unbounded and Intelligent Decentralization (FLUID) experiment, NASA will run an AI neural net model trained on data from Earth, the Moon, and on the International Space Station, demonstrating coordination of three separate AI models. NASA will also conduct a tuned LLM test with semantic processing abilities to assist in searching and interpreting onboard documents.Deloitte's Silent Shield™, a new system to detect cyber intrusions, will provide near real-time, predictive cyber-analytics and anomaly detection.Building on the years of successful deployment on the International Space Station, HPE Spaceborne Computer-4 is the latest successor to the HPE Spaceborne Computer project that will deliver real-time, advanced data processing to the newest frontiers of far-edge computing.
About HPE
HPE (NYSE: HPE) is a leader in essential enterprise technology, bringing together the power of AI, cloud, and networking to help organizations achieve more. As pioneers of possibility, our innovation and expertise advance the way people live and work. We empower our customers across industries to optimize operational performance, transform data into foresight, and maximize their impact. Unlock your boldest ambitions with HPE. Discover more at www.hpe.com.
___________________________
1 Based on analysis of publicly available information as of October 20, 2026, no other company or organization has conducted the specific HPC benchmarks that HPE plans to execute on the surface of the Moon, nor will any planned mission with HPC by other parties take place on the Moon prior to HPE’s mission.
2 HPE Spaceborne Computer-4 to run high-performance LINPACK (HPL) and high-performance conjugate gradient (HPCG) on the surface of the Moon.
As used in this document, “Deloitte” means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of our legal structure. Certain services may not be available to attest clients under the rules and regulations of public accounting.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261020987784/en/
Become a Premium Member to See This: (Free Trial):
List of 52-Week Lows, 52-Week Highs List of 3-Year Lows, 3-Year Highs List of 5-Year Lows, 5-Year Highs
Disclosures
I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
As enterprise automation and cybersecurity converge, investors are weighing the potential of specialized software providers. Both C3.ai (AI +0.04%) and SentinelOne (S +0.74%) offer unique exposure to artificial intelligence, but they face different financial trajectories.
C3.ai focuses on enterprise-level applications that help organizations integrate predictive models into their operations. SentinelOne provides autonomous cybersecurity that protects digital assets without human intervention.
Comparing these two tech stocks reveals how growth rates and profitability goals shape the investment thesis for 2026.
C3.ai provides a comprehensive suite of enterprise AI applications designed to accelerate digital transformation. The company sells its C3 Agentic AI Platform to diverse sectors, including manufacturing, utilities, and the federal government. Strategic partners like Baker Hughes (BKR -0.66%) and Microsoft (MSFT +0.88%) help drive adoption through reseller and co-sell agreements. This dependency adds a layer of risk to the business, though the company is shifting toward smaller contract sizes to broaden its base.
In its 2026 fiscal year (FY), ended April 30, revenue reached nearly $250.3 million, which represented a decline of 35.7% from the previous fiscal year. This revenue contraction coincided with a net loss of $470.4 million. The company reported a net margin of negative 187.9%, indicating that expenses significantly outpaced total sales. This trend follows a shift in the go-to-market strategy that emphasizes consumption-based pricing over large, upfront subscription fees.
As of its April 2026 balance sheet, the current ratio stands at 6.6x. The current ratio measures a company's ability to cover its short-term liabilities with its short-term assets. Its debt-to-equity ratio, which compares total debt to shareholder equity, was zero, indicating the company has no debt relative to its equity base. Free cash flow, which is cash flow from operations minus capital expenditures, was negative $190.7 million for the fiscal year.
The case for SentinelOneSentinelOne utilizes artificial intelligence to power its Singularity Platform, which secures endpoints, cloud workloads, and identity credentials. The company relies heavily on a global ecosystem of channel partners, such as resellers and managed service providers, to reach its customers. By automating threat detection and response, the platform aims to replace traditional antivirus software with a more proactive security layer. Its global reach extends across various industries and government sectors through these strategic alliances.
In FY 2026, ended Jan. 31, revenue reached $1.0 billion, a growth rate of 21.9% compared to the previous year. Despite this top-line expansion, the company reported a net loss of $450.7 million. The net margin for the period was negative 45%, which is an improvement from some earlier fiscal periods. This growth indicates that the company is successfully scaling its footprint in the competitive cybersecurity market.
As of its January 2026 balance sheet, the current ratio is 1.4x. The debt-to-equity ratio is zero, meaning total liabilities do not outweigh the company's equity through traditional debt. Free cash flow for the fiscal year was positive at approximately $75.9 million. Note that stock-based compensation represented roughly 388.4% of operating cash flow, meaning reported cash generation is heavily inflated by this non-cash add-back.
Risk profile comparisonC3.ai faces significant operational risks as it continues to report net losses and undergoes a restructuring plan initiated in February 2026. The success of this efficiency-focused plan is not guaranteed and could cause further disruption to its sales efforts. The company also deals with long and unpredictable sales cycles, particularly when dealing with government entities. Furthermore, the market for enterprise AI is intensely competitive, with Microsoft and other large incumbents offering rival solutions.
SentinelOne operates in a cybersecurity market that is both fragmented and rapidly evolving. The company faces stiff competition from established vendors that have significantly larger product portfolios and more resources. Because the platform is primarily hosted on Amazon (AMZN +4.94%), any disruption to this cloud hosting relationship could impact service delivery. Additionally, as a security provider, the company is a high-value target for cyberattacks, and any perceived vulnerability could damage its reputation.
Valuation comparisonSentinelOne trades at a lower valuation relative to its sales, while C3.ai does not have future earnings estimates.
MetricC3.aiSentinelOneForward P/En/a71.5xP/S ratio6.8x7.1xValuation metrics include sourcing from Financial Modeling Prep (FMP) and may differ from other data providers.
Which stock would I buy in 2026?I have invested in C3.ai and SentinelOne, but between the two, I recommend investing in the latter. I bought SentinelOne stock because it was one of the early cybersecurity companies to employ AI in its platform. Now, AI is a growing threat to organizations around the world, because the tech can quickly and efficiently find security vulnerabilities. For example, AI going rogue hacked into Hugging Face recently.
This environment makes SentinelOne's AI-powered platform capable of repelling tech-driven hacks. The company's rising revenue illustrates the success of its technology. Its strong sales in FY 2026 continues in the current fiscal year, with Q2 revenue growth of 21% year over year to $292 million.
C3.ai looked like a compelling AI company when I invested, but then its CEO Thomas Siebel stepped down due to health issues last year. That contributed to C3.ai's 35.7% drop in revenue.
Siebel returned in June, and in its fiscal Q1, ended July 31, the company announced customer bookings growth of 73% quarter over quarter, suggesting his return is helping to turn the business around. That said, given its stock's valuation is on par with SentinelOne and the uncertainty with how the turnaround will progress, SentinelOne is the better stock to buy.
In the latest trading session, C3.ai, Inc. (AI - Free Report) closed at $11.33, marking a -6.83% move from the previous day. The stock's change was less than the S&P 500's daily loss of 1.09%. On the other hand, the Dow registered a loss of 0.34%, and the technology-centric Nasdaq decreased by 2.15%.
Shares of the company have appreciated by 12.8% over the course of the past month, outperforming the Computer and Technology sector's gain of 1.99%, and the S&P 500's gain of 2.44%.
Analysts and investors alike will be keeping a close eye on the performance of C3.ai, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be -$0.22, reflecting a 12% increase from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $53.1 million, indicating a 29.34% decline compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of -$0.76 per share and a revenue of $223.01 million, demonstrating changes of +43.7% and -10.89%, respectively, from the preceding year.
Investors should also pay attention to any latest changes in analyst estimates for C3.ai, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.36% lower. C3.ai, Inc. currently has a Zacks Rank of #3 (Hold).
The Computers - IT Services industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 148, positioning it in the bottom 40% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
U.S. companies and the Trump administration both "need to be wary" of foreign espionage attempts as the race for artificial intelligence dominance continues, Director of National Intelligence Jay Clayton told CNBC on Friday.
AI "amplifies" existing cybersecurity risks toward U.S. digital infrastructure, which is interconnected with critical systems related to everything from public goods to the national defense and global communications, Clayton said on "Squawk Box."
It's "why we're focused on hardening those systems" and using "our commitment to continue to lead to stay ahead of those nefarious actors," said Clayton, who leads a new White House AI task force.
Clayton was asked how concerned Americans should be with the threat of foreign spying in light of the recently revealed case charging Saudi national Abdulrahman Alfozan with allegedly installing a recording device in an OpenAI executive conference room. Alfozan has not been charged with espionage; the federal charge involves alleged interception of oral communications.
Alfozan, who was an OpenAI employee, had booked a one-way plane ticket to Saudi Arabia with his wife and another family member prior to his arrest, according to federal prosecutors.
"The short answer to your question is espionage, both commercial espionage, and I would say state-sponsored espionage, are realities," Clayton said.
"It's something that our private sector companies need to be wary of. We, as a government, need to be wary of," he said.
The OpenAI incident "shows the lengths that people will go to try and supplant our leadership in this, or at least stay close to us in this emerging technology," Clayton said.
An ex-CIA official, speaking on condition of anonymity to discuss non-public information, told CNBC this week that the case is "probably the tip of the iceberg."
Clayton, who was appointed AI czar earlier this month, said that the task force's "very good" inaugural meeting at the White House on Thursday built on the accord signed by President Donald Trump and a number of AI leaders at the White House last month. Trump had described the agreement, which includes industry pledges to police AI risks itself, as "morally binding."
The task force also established three subcommittees that are focused on different AI-related issues. One is tasked with reporting and response, another with assessing critical infrastructure and working with the private sector, and a third with law enforcement and responsibility, Clayton said.
The DNI reiterated to CNBC that the Trump administration is intent on staying ahead in the AI race.
"We're not the only ones developing it. There are vectors in this technology that are coming from some of our known adversaries and competitors," he said. "The Chinese, the Russians, the Iranians, the North Koreans all have significant technical capability. We need to stay ahead of them."
Insperity Unveils Its AI Capabilities for the Future of HR Highlighting New Insperity HR360 AI Agent As organizations navigate a workplace increasingly shaped by artificial intelligence (AI), Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for small to midsize businesses, announced its approach to help clients analyze and transform their workforce in the AI era.
Insperity's AI strategy spans the enterprise, supporting employees, client-facing service teams and external customers through Insperity’s growing AI capabilities connecting AI to extensive HR expertise and proprietary knowledge.
"HR decisions require judgment, expertise and a deep understanding of people," said Paul Sarvadi, chairman and chief executive officer of Insperity. "Our strategy combines the power of AI with the experience of our HR professionals to strengthen the speed and consistency of the client experience, while advancing access to actionable insights through conversational intelligence."
Meet the Insperity HR360 AI Agent
Insperity continues to invest in AI-powered capabilities that help businesses navigate workforce challenges, improve productivity and make smarter decisions. At the heart of that vision is the HR360 AI Agent, an exciting new capability being rolled out within Insperity's existing best-in-class Insperity HR360 solution. This AI Agent is designed to help clients get faster answers to HR questions, more easily access workforce insights and navigate HR responsibilities with greater confidence.
Access to HR experts and personalized service will remain a hallmark of the Insperity service delivery model, helping clients resolve HR challenges and implement people strategies to transform their business.
Faster Answers
The new AI Agent handles everyday HR administration questions and guides users directly to the correct location within the Insperity HR360 solution to complete a task. Whether an administrator needs to add a new manager, update employee information or understand required training, the HR360 AI Agent can provide direction and users can ask follow-up questions and receive responses that build on previous interactions, creating a more intuitive and efficient way to navigate HR responsibilities.
The AI Agent is also designed to help managers lead important people-related moments by providing information, guidance and resources ranging from performance review preparation to coaching development.
This helps leaders spend less time searching for answers and more time focusing on developing employees and growing their business.
Personalized Guidance Grounded in Company Policies
Many HR questions depend on company-specific policies rather than generic information. The HR360 AI Agent is designed to help users access guidance informed by their company policies and resources maintained with Insperity. For example, when an administrator asks about the vacation accrual process for an employee hired mid-year, the system can draw from the organization's specific policy.
Conversational Workforce Intelligence
Future capabilities under development for the HR360 AI Agent include providing workforce insights, as clients will be able to ask questions and receive insights in an intuitive, conversational format. The planned functionality would allow users to enter simple commands such as "show me headcount by location" or “how have our employee engagement metrics trended over time,” and receive reports, graphic visualizations and contextual insights, helping leaders access information more quickly and make better-informed workforce decisions.
AI That Strengthens Human Partnerships
The HR360 AI Agent provides quick access to valuable information and insights, while maintaining a direct path to Insperity specialists when situations require expertise, judgment or consultation. To help companies be successful in the era of AI transformation, Insperity is combining the convenience of AI with the confidence of human support to create a new service delivery model to support small and mid-sized businesses and their employees in the years ahead.
About Insperity
Since 1986, Insperity’s mission has been to help businesses succeed so communities prosper. Offering a suite of the most comprehensive, scalable HR solutions available in the marketplace, Insperity is defined by an unrivaled breadth and depth of services and level of care. Through an optimal blend of premium HR service and technology, Insperity delivers the administrative relief, reduced liabilities and better benefit solutions that businesses need to drive performance and growth. With 2025 revenues of $6.8 billion and sales and service operations throughout the U.S., Insperity is currently making a difference in thousands of businesses and communities nationwide. For more information, visit http://www.insperity.com.
Forward-Looking Statements
This press release contains forward-looking statements including, among other things, statements regarding Insperity’s plans, beliefs, and expectations. These forward-looking statements are based only on currently available information and Insperity’s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, such as to plans, strategies, projected or anticipated benefits, or other future events, they are subject to inherent risks, uncertainties, assumptions, and changes in circumstances that are difficult to predict and many of which are outside of Insperity’s control. If the risks materialize, assumptions prove incorrect, or we experience unexpected changes in circumstances, actual results could differ materially from the results implied by these forward-looking statements, and therefore you should not rely on any forward-looking statements. Risks include, but are not limited to, risks described in Insperity’s filings with the Securities and Exchange Commission such as Insperity’s Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, any of which could cause actual results to vary from expectations. Insperity does not assume any obligation to, and does not currently intend to, update any such forward-looking statements after the date of this release, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261015752898/en/
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
[url="]bioAffinity Technologies, Inc.[/url] (Nasdaq: BIAF; BIAFW),a biotechnology company developing noninvasive healthcare solutions for the early detection an
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease, today announced it will present new data at CHEST 2026, the annual meeting of the American College of Chest Physicians, on the Company's sputum-based tests in development to characterize lung inflammation and detect multiple protein biomarkers of lung inflammation, including biologic drug targets of therapeutics used to treat asthma and chronic obstructive pulmonary disease (COPD).
By providing a more complete picture of a patient's inflammatory profile, this research approach may, with further development and validation, help inform identification of patients who could benefit from specific biologic therapies and support monitoring of lung inflammation over time, consistent with a precision medicine approach.
bioAffinity Technologies will present a poster, titled "Sputum as a Diagnostic Tool for the Measurement of Lung Inflammation in Asthma," that describes a workflow based on the proprietary flow cytometry + AI platform used by the Company's commercially available noninvasive CyPath® Lung diagnostic for lung cancer.
The poster reports research on measuring key cytokines and cell-surface receptors involved in lung inflammation, including targets of approved and emerging biologic therapies for asthma and COPD. Data show that the test in development can detect multiple targets in sputum using a combination of cellular and proteomic analysis. Data are specifically provided for soluble and cellular biologic drug targets that play different roles in driving inflammation:
TSLP: an epithelial alarmin that is an early trigger of inflammation. It is targeted by tezepelumab (Tezspire) and related drugs.CRLF2: a cell-surface receptor for TSLP targeted by the investigational therapeutic verkitug.IL4-Ra (CD124): a receptor subunit present in IL-4 and IL-13 receptors involved in Th2 asthma inflammation and some forms of COPD. It is targeted by dupilumab (Dupixent).IL-5: a cytokine that promotes the growth and activity of eosinophils, immune cells involved in eosinophilic asthma and some COPD. It is targeted by mepolizumab (Nucala).References to these and other branded therapeutics identify biological pathways and drug targets studied in the research and do not constitute a claim that the Company's test in development can be used to select, guide, monitor or otherwise inform the use of any named therapy. The test described is investigational and not yet available for clinical or diagnostic use.
According to the Asthma and Allergy Foundation of America1, an estimated 28 million Americans have asthma, including 5 million children, or seven out of 100 people under the age of 18. In 2020, asthma accounted for nearly 100,000 discharges from hospital inpatient care and almost 1 million emergency department visits. The global asthma therapeutics market is estimated at approximately $29.7 billion in 2025, projected to reach $47.6 billion by 2034.2 The market includes a growing range of biologic therapies that target specific pathways involved in inflammation.
"Lung inflammation in asthma is complex and heterogeneous, and clinicians need better tools to characterize what is happening in the lung and understand differences among patients," said Gordon Downie, MD, PhD, bioAffinity Technologies Chief Medical Officer. "We believe this research represents an important step toward a better understanding of distinct types of lung inflammation and targeted treatment specific to each patient."
Dr. Downie will lead a discussion at CHEST 2026 on the clinical use of CyPath Lung and the development of sputum-based tests to characterize lung inflammation in patients with asthma and COPD. The discussion will take place in Learning Theater 4 at 12:30 p.m. on October 21.
In the study, sputum samples were collected from people with asthma, smokers without asthma, smokers with COPD, a smoker with both COPD and asthma, and healthy individuals. Immune cell populations were analyzed by flow cytometry and inflammatory proteins (cytokines) were measured by an enzyme-linked immunosorbent assay (ELISA). The combined data were analyzed using machine learning.
By measuring the inflammatory markers in sputum, the Company’s ongoing research aims to improve understanding of different patterns of lung inflammation, with the goal of ultimately helping identify and monitor patients who may be most likely to benefit from specific treatments, subject to further research and validation.
"Our research shows the potential to measure cellular and protein features directly from sputum, including selected targets associated with specific biologic drugs," said William Bauta, PhD, bioAffinity Technologies Chief Science Officer. "We believe this test could provide a more detailed picture of lung inflammation and, with further study, help doctors discern among treatment options and track inflammatory changes in the lung over time."
CHEST 2026 Presentation Details
Title: Sputum as a Diagnostic Tool for the Measurement of Lung Inflammation in Asthma
Poster: 3071
Session: Original Investigation / Allergy-Airway
Date: October 20, 2026
Time: 1:45–2:30 p.m.
Location: Phoenix Convention Center, Phoenix, AZ
About CyPath Lung
CyPath Lung by bioAffinity Technologies is a noninvasive test designed to improve the early detection of lung cancer in patients at high risk for the disease. CyPath Lung uses advanced flow cytometry and proprietary artificial intelligence (AI) to identify cell populations in patient sputum that indicate malignancy. CyPath Lung incorporates a novel fluorescent porphyrin that is preferentially taken up by cancer and cancer-related cells. In a published clinical trial of high-risk patients, CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy and 99% negative predictive value (NPV) in detecting lung cancer in patients at high risk for the disease who had small indeterminate lung nodules less than 20 millimeters. The high NPV may help inform physician decision-making when evaluating whether further invasive procedures are warranted. CyPath Lung is marketed as a Laboratory Developed Test (LDT), is not intended for use as a sole diagnostic tool, and should be considered alongside other clinical findings. For more information, visit www.cypathlung.com.
About bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc. addresses the need for noninvasive diagnosis of early-stage cancer and other diseases of the lung and broad-spectrum cancer treatments. The Company’s first product, CyPath Lung, is a noninvasive test that has shown high sensitivity, specificity and accuracy for the detection of early-stage lung cancer. CyPath Lung is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Laboratory Services, a subsidiary of bioAffinity Technologies. LDTs are overseen under the Clinical Laboratory Improvement Amendments (CLIA), which are administered by the Centers for Medicare & Medicaid Services. For more information, visit www.bioaffinitytech.com.
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict, that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding: the Company's research and development of sputum-based tests to characterize lung inflammation and detect protein biomarkers, including biologic drug targets, for asthma and COPD; the potential clinical utility, benefits, or future availability of such tests, including their potential to help identify or monitor patients who may benefit from specific biologic therapies or to support a precision medicine approach; the Company's plans and expectations regarding ongoing research, development, and validation of its sputum-based tests; expectations regarding the content and conclusions of the poster presentation and discussion at CHEST 2026; projections of the global asthma therapeutics market size, including the estimate that the market will reach $47.6 billion by 2034; and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. While the Company believes these forward-looking statements are reasonable, readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The information in this release is provided only as of the date of this release, and the Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
1 Asthma and Allergy Foundation of America, Asthma Fact and Figures
2 Fortune Business Insights, Asthma Therapeutics Market Size, Share & Industry Analysis, September 2026
View source version on businesswire.com: https://www.businesswire.com/news/home/20261013780632/en/
C3.ai, Inc. (AI - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of this company have returned +3.9% over the past month versus the Zacks S&P 500 composite's +2.1% change. The Zacks Computers - IT Services industry, to which C3.ai belongs, has gained 1.6% over this period. Now the key question is: Where could the stock be headed in the near term?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Revisions to Earnings EstimatesHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
C3.ai is expected to post a loss of $0.22 per share for the current quarter, representing a year-over-year change of +12%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The consensus earnings estimate of -$0.76 for the current fiscal year indicates a year-over-year change of +43.7%. This estimate has changed -0.4% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $0.46 indicates a change of +39.6% from what C3.ai is expected to report a year ago. Over the past month, the estimate has changed -2.1%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, C3.ai is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of C3.ai, the consensus sales estimate of $53.1 million for the current quarter points to a year-over-year change of -29.3%. The $222.61 million and $248.97 million estimates for the current and next fiscal years indicate changes of -11.1% and +11.8%, respectively.
Last Reported Results and Surprise HistoryC3.ai reported revenues of $52.38 million in the last reported quarter, representing a year-over-year change of -25.4%. EPS of -$0.2 for the same period compares with -$0.37 a year ago.
Compared to the Zacks Consensus Estimate of $51.46 million, the reported revenues represent a surprise of +1.79%. The EPS surprise was +23.08%.
Over the last four quarters, C3.ai surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
C3.ai is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about C3.ai. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
As the era of agentic automation arrives, C3.ai (AI +0.69%) and UiPath (PATH -1.19%) offer different ways to play the trend. Choosing between them requires weighing specialized applications against broad business process orchestration.
C3.ai focuses on pre-built enterprise applications for specific industries like energy and defense. UiPath started in robotic process automation and has evolved into an AI-powered platform for automating complex workflows. Both companies are fighting for dominance as corporations move from experimenting with generative tools to deploying full-scale automated agents.
The case for C3.aiC3.ai provides the C3 Agentic AI Platform, which allows organizations to build and deploy artificial intelligence applications. It serves customers in sectors like defense and energy, though it has recently revised its partnership with Baker Hughes (BKR -0.92%). Customer concentration like this adds a layer of risk to the business, as the company works to transition more clients to a consumption-based pricing model.
In FY 2026, revenue reached approximately $250.3 million, representing a decline of roughly 35.7% from the previous year. The company reported a net loss of nearly $470.4 million during this period. This performance followed a wider net loss than seen in FY 2025, when the company recorded a net margin of close to negative 74.2%.
As of its April 2026 balance sheet, the current ratio stands at approximately 6.6x. The current ratio measures a company's ability to cover its short-term debts with assets that can be converted to cash within a year.
The debt-to-equity ratio is 0.0x, indicating the company carries no debt relative to shareholder equity. Free cash flow for FY 2026 was nearly negative $190.7 million.
The case for UiPathUiPath offers a platform that combines automation with AI to orchestrate business processes. The company targets large enterprises and recently deepened its technical integration with Snowflake (SNOW -2.31%) to enable data-driven automation. This helps users manage workflows across various tech stocks and services within their existing digital infrastructure.
In FY 2026, revenue reached approximately $1.6 billion, a growth of roughly 12.7% compared to the prior fiscal year. The company achieved a net income of close to $282.3 million. This resulted in a net margin of approximately 17.5%, a significant improvement over the negative net margin reported in FY 2025.
As of its January 2026 balance sheet, the debt-to-equity ratio was 0.0x, meaning UiPath has no debt on its books. Free cash flow for FY 2026 reached nearly $352.2 million. Note that stock-based compensation represented roughly 78.3% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement.
Risk profile comparisonC3.ai faces risks from a limited number of large enterprise customers representing a substantial portion of its revenue. Following its February 2026 restructuring plan, the company also faces challenges regarding employee attrition and the potential loss of institutional knowledge. Competition remains intense from Microsoft (MSFT +1.14%) and other established software vendors that are rapidly integrating agentic AI into their own products.
UiPath faces risks related to the sustainability of its growth as the automation market matures and competition increases from Amazon (AMZN -1.10%) and Salesforce (CRM +2.09%). The company relies heavily on third-party cloud infrastructure, meaning any service disruptions could impact its financial results. Furthermore, ongoing tax disputes in jurisdictions like Romania and India present compliance risks that could lead to material financial harm.
Valuation comparisonUiPath offers a lower entry point for investors based on its profitability and lower valuation multiples compared to C3.ai.
MetricC3.aiUiPathForward P/EN/A17.1xP/S ratio7.5x4.2xValuation metrics include sourcing from Financial Modeling Prep (FMP) and may differ from other data providers.
The P/S ratio measures a company's market price against its sales over the past twelve months. The Forward P/E ratio compares the current stock price to future earnings estimates for the next year.
I'd go with UiPath. After years of testing investor patience, the company has now been consistently profitable for several consecutive quarters, raised its full-year outlook, and is finding new customers among businesses deploying AI automation across their operations. Its turnaround seems to be gaining traction and the business is moving in the right direction.
C3.ai is a much harder story to get behind right now. In Q1 fiscal 2027, bookings grew 73% quarter over quarter, revenue stabilized at roughly $52 million, and the company turned free cash flow positive for the first time, which is a meaningful step in the right direction. But C3.ai is still posting substantial net losses on a trailing basis, and the restructuring under returning CEO Thomas Siebel is still in its early stages.
UiPath has already cleared many of the hurdles C3.ai is still working toward. If I’m thinking about where to put my money for the next several years, owning the company that has already figured out how to be profitable is the more comfortable starting point for me.
C3.ai, Inc. (NYSE:AI – Get Free Report)’s stock price gapped up before the market opened on Monday. The stock had previously closed at $11.53, but opened at $12.30. C3.ai shares last traded at $12.1790, with a volume of 3,511,581 shares.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on AI. Canaccord Genuity Group reiterated a “hold” rating and issued a $10.00 target price on shares of C3.ai in a report on Thursday, September 3rd. Citigroup reissued a “market perform” rating on shares of C3.ai in a research report on Thursday, September 3rd. Northland Securities set a $16.00 price target on C3.ai and gave the stock an “outperform” rating in a research note on Monday. Weiss Ratings upgraded C3.ai from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, August 4th. Finally, Needham & Company LLC restated a “hold” rating on shares of C3.ai in a research report on Thursday, September 3rd. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and seven have issued a Sell rating to the stock. According to data from MarketBeat.com, C3.ai presently has a consensus rating of “Reduce” and an average target price of $9.36.
Check Out Our Latest Report on AI
C3.ai Stock Up 3.7%
The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of -3.89 and a beta of 2.11. The stock has a 50-day moving average price of $10.51 and a 200 day moving average price of $9.70.
C3.ai (NYSE:AI – Get Free Report) last released its earnings results on Wednesday, September 2nd. The company reported ($0.20) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.06. The firm had revenue of $52.38 million for the quarter, compared to analyst estimates of $52.06 million. C3.ai had a negative net margin of 192.10% and a negative return on equity of 61.25%. The business’s quarterly revenue was down 25.4% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.37) earnings per share. As a group, equities analysts forecast that C3.ai, Inc. will post -2.21 earnings per share for the current fiscal year.
Insider Activity at C3.ai
In other C3.ai news, CFO Hitesh Lath sold 21,077 shares of the stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $10.48, for a total value of $220,886.96. Following the sale, the chief financial officer directly owned 371,036 shares of the company’s stock, valued at approximately $3,888,457.28. This represents a 5.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Thomas Siebel sold 453,314 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $10.51, for a total transaction of $4,764,330.14. Following the completion of the sale, the chief executive officer owned 722,362 shares in the company, valued at $7,592,024.62. The trade was a 38.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,117,809 shares of company stock valued at $11,724,230 in the last quarter. 19.80% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On C3.ai
Several large investors have recently bought and sold shares of the business. Arizona State Retirement System lifted its stake in C3.ai by 3.7% during the second quarter. Arizona State Retirement System now owns 37,168 shares of the company’s stock worth $338,000 after purchasing an additional 1,310 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in C3.ai by 12.7% in the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 13,776 shares of the company’s stock valued at $116,000 after purchasing an additional 1,548 shares during the last quarter. CoreCap Advisors LLC increased its stake in C3.ai by 34.0% in the second quarter. CoreCap Advisors LLC now owns 6,145 shares of the company’s stock valued at $56,000 after purchasing an additional 1,560 shares during the last quarter. Western Wealth Management LLC purchased a new position in C3.ai in the first quarter valued at approximately $26,000. Finally, Allworth Financial LP raised its holdings in C3.ai by 13.6% during the second quarter. Allworth Financial LP now owns 26,660 shares of the company’s stock worth $242,000 after purchasing an additional 3,185 shares in the last quarter. Hedge funds and other institutional investors own 38.96% of the company’s stock.
About C3.ai
(Get Free Report)
C3.ai, Inc is an enterprise artificial intelligence software company that develops applications and tools designed to help organizations use AI and machine learning to analyze data, automate processes and support business decision-making. The company’s offerings are intended for large commercial enterprises, government agencies and other organizations managing complex operational and data environments.
Its product portfolio includes the C3 AI Platform, which provides capabilities for developing, deploying and operating AI applications, as well as prebuilt enterprise applications.
See Also
Five stocks we like better than C3.ai
3 REITs That May Win in a Higher Interest Rate Environment
Broadcom’s Anthropic Bet Gets Bigger as $60 Billion Financing Raises the Stakes
Insider Buying Signals Opportunity in H.B. Fuller, FocalTherics, Cardinal
5 Retail Picks to Watch as the Holiday Shopping Season Nears
Receive News & Ratings for C3.ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3.ai and related companies with MarketBeat.com's FREE daily email newsletter.
C3.ai Inc (AI) stock is pushing higher on Monday morning after Northland Capital issued a bullish note in favour of the enterprise artificial intelligence software company. In his research note, analyst Mike Latimore upgraded AI to Outperform, and raised his price target to $16, indicating potential upside of more than 40% from its previous close.
The Hackett Group, Inc. (NASDAQ: HCKT), an enterprise AI transformation firm, today announced AI World Class Supply Chain benchmarks – new research that quantifies how AI is reshaping supply chain performance and reveals a growing gap between organizations redesigning supply chains around AI and those that ignore agentic automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261012870299/en/
While many organizations focus on automating individual supply chain activities, AI World Class reveals a larger opportunity: redesigning the entire end-to-end process around AI. Improvements across planning, inventorymanagement, manufacturing, warehousing, transportation and returns compound. Better decisions upstream reduce work downstream, improving service, working capital and cost throughout the process. The gains land at both ends of the process. AI World Class modeling shows process costs across plan-to-deliver can decline by 12% to 17%, while staffing requirements decline by 15% to 24%. Source: AI World Class Supply Chain benchmark modeling based on peer median and AI World Class performance scenarios, The Hackett Group®, 2026
The research indicates that the next phase of enterprise AI adoption will be defined by operational outcomes. As tariff exposure, demand volatility and margin pressure continue to intensify, supply chain leaders are increasingly expected to improve service reliability, strengthen resilience, improve working capital management and absorb disruption without proportional increases in resources.
“Most organizations still approach AI as a collection of planning tools and isolated use cases,” said Erin Blair, principal at The Hackett Group®. “Leading companies are using AI to rethink how their supply chains and teams operate. The result is not simply greater efficiency, but measurable improvements in working capital, service reliability, operating leverage and resilience.”
The new AI World Class Supply Chain benchmarks span critical plan-to-deliver processes, including planning, inventory management, manufacturing, warehousing, transportation, fulfillment and returns. They quantify where process-led AI transformation can create the greatest value and establish future-state performance standards for organizations pursuing AI-enabled transformation.
Plan-to-deliver provides one of the clearest examples of how AI creates compounding value. Better demand sensing, inventory optimization and execution decisions reinforce one another throughout the process, reducing complexity and improving service, cost, and working capital outcomes.
The results are significant. AI World Class modeling shows organizations can reduce forecast error by up to 52%, lower inventory carrying costs by up to 41% and reduce obsolete inventory by up to 36%. As inventory is positioned more accurately across the network, warehouse execution improves, shortening pick-to-ship cycle times by up to 38% and accelerating returns processing by up to 40%.
The impact becomes even more visible downstream. Expedited orders decline by up to 59%, while shipment-to-delivery cycle times improve by up to 25%. As disruption and recovery work are reduced throughout the network, on-time in-full performance rises into the high 90% range, strengthening both customer outcomes and operational resilience.
“Supply chain performance is no longer determined solely by automation or efficiency,” said Sid Shetty, senior manager at The Hackett Group®. “Organizations that redesign work around AI are changing how their supply chains operate. Better decisions earlier in the process reduce the work, cost and disruption the rest of the network has to absorb. That is where AI created a more sustainable competitive advantage.”
The findings also demonstrate the broader economic impact of AI-enabled supply chain transformation. AI World Class modeling shows plan-to-deliver process costs can decline by 12% to 17%, while staffing requirements can decrease by 15% to 24%, creating capacity for higher-value activities across the supply chain organization.
While plan-to-deliver provides a clear illustration of the opportunity, similar patterns emerge across the broader AI World Class benchmark portfolio. The benchmarks span 16 end-to-end enterprise processes and identify where process reinvention can unlock the greatest gains in cost, productivity, speed, quality and business performance. The most significant value is created when organizations redesign how work flows across an entire process enabled by AI rather than focusing on isolated automation opportunities.
The AI World Class benchmarks are grounded in more than 30 years of benchmark data, process intelligence and transformation experience drawn from leading global organizations, including 98% of the Dow Jones Global Titans, 97% of the Dow Jones Industrials and 90% of the Fortune 100. AI World Class extends The Hackett Group’s Digital World Class® methodology to model the next generation of performance achievable through AI-enabled execution.
The AI World Class Supply Chain benchmarks are available exclusively through The Hackett Group®. Download the AI World Class Supply Chain report to learn how process-led AI transformation is creating a growing supply chain performance gap and where organizations can capture the greatest value.
About The Hackett Group®
The Hackett Group, Inc. (NASDAQ: HCKT) is an ROI-led, AI enterprise transformation firm that helps clients enable AI World Class performance. Its experts and engineers leverage Hackett AI platforms, including XT™, AIXelerator™, Hackett AI XPLR™, ZBrain® and XDA™, to accelerate and enhance the delivery of the company’s solutions and services.
The Hackett AI platforms are powered by the company’s domain-specific Solution Language Model informed by Hackett Process and Performance Intelligence, including Digital World Class® and AI World Class benchmark metrics, industry-specific best-practice process flows and service delivery model frameworks. The Hackett Group’s proprietary insights are based on benchmarking results from leading global organizations, including 98% of Dow Jones Global Titans, 97% of the Dow Jones Industrials and 90% of the Fortune 100. Visit www.thehackettgroup.com.
Trademarks
The Hackett Group®, quadrant logo, ZBrain® and Digital World Class® are the registered marks of The Hackett Group®.
This release contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements including without limitation, words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” or other similar phrases or variations of such words or similar expressions indicating, present or future anticipated or expected occurrences or outcomes are intended to identify such forward-looking statements. Forward-looking statements are not statements of historical fact and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. Factors that may impact such forward-looking statements include without limitation, the ability of The Hackett Group® to effectively market its digital transformation services, our ability to transition our capabilities to support generative artificial intelligence (AI)-related consulting services and solutions and other consulting services, our ability to effectively integrate acquisitions into our operations, our ability to manage joint ventures and successfully cooperate with our joint venture partners, competition from other consulting and technology companies that may have or develop in the future, similar offerings, the commercial viability of The Hackett Group® and its services as well as other risk detailed in The Hackett Group’s reports filed with the United States Securities and Exchange Commission. The Hackett Group® does not undertake any duty to update this release or any forward-looking statements contained herein.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261012870299/en/
Disclosures
I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Agentic software stocks are splitting in opposite directions this session, and the reason one name keeps sinking while another surges on an upgrade reveals how the market now grades companies in this corner of tech.
Agentic software names are splitting apart, and the gap says a lot about how the market grades this group. SoundHound AI (NASDAQ:SOUN) stock is at $5.14, down 5% early in the session and sitting at fresh lows. That leaves SoundHound stock down 48% so far this year.
Meanwhile, C3.ai (NYSE:AI | AI Price Prediction) stock is at $11.98, up 4% after an analyst upgrade. UiPath (NYSE:PATH) stock is at $13.26, down 2%, a smaller slide than the one in SoundHound stock.
Software as a group is lower, with the iShares Expanded Tech-Software Sector ETF (CBOE:IGV) at $111.83, down 0.8%. Large caps are calmer, with the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) virtually unchanged at $778.32. Against that background, the drop in SoundHound stock runs far deeper than the sector fund’s dip, which points to selling aimed at the name itself.
Northland Upgrade Lifts C3.ai on Agentic Build Tool Northland Capital upgraded C3.ai stock to Outperform from Market Perform, and analyst Mike Latimore lifted the firm’s price target to $16. Latimore pointed to a newly launched development product that lets customers create agentic applications using natural language, with autonomous software handling the build work. In his view, the product can shrink the time to create those applications to days from months.
Faster builds could speed customer onboarding and expansion at existing accounts, according to Latimore. C3.ai’s Q1 FY2027 results showed bookings up 73% quarter over quarter and free cash flow turning positive, though revenue fell 25.5% year over year. Its cash balance of $651.1 million gives the company a deep buffer to fund that push while its turnaround plays out.
SoundHound Keeps Sliding as Its Share Count Grows SoundHound stock is setting fresh lows. The drop is part of a continuing de-rating, and the company hasn’t issued an announcement of its own to explain the move. The company completed its acquisition of LivePerson on September 4, a stock-funded deal that enlarged its share count. Each new share spreads ownership thinner, and that pressure lands while SoundHound is still reporting losses.
Paying for acquisitions in stock while losses continue asks existing shareholders to fund the growth, skeptics say. At the end of Q2 2026, SoundHound held $202.8 million in cash, while stock-based compensation reached $21.5 million in that quarter. Both figures highlight the dilution question as the combined company scales up.
Supporters see the setup differently. They note that the agentic demand Northland just cited is the same market SoundHound targets, now with a larger installed base from LivePerson to sell to. Growth has also been strong, with SoundHound’s revenue up 45% year over year in Q2 2026. Keyvan Mohajer, SoundHound’s chief executive, stated on the Q2 2026 earnings call, “There is a very high potential turnaround opportunity via this acquisition.”
What to Watch Next One agentic name rising on an analyst upgrade while another makes fresh lows suggests the market is sorting this group by balance sheet, as C3.ai carries a far larger cash pile than SoundHound, which has leaned on its own shares to fund expansion. UiPath stock and the software fund both show much smaller drops than SoundHound stock, which keeps the pressure focused on one name.
The first set of results that includes LivePerson is the next major checkpoint for SoundHound. That report can show whether the larger installed base lifts revenue faster than it adds to losses. Investors may want to check for whether SoundHound funds its spending with further share sales and consider that dilution risk when deciding how much to own.
Contact [email protected] for any questions or corrections.
C3.Ai Inc. (NYSE:AI) shares are trading higher Monday after Northland upgraded the stock to Outperform from Market Perform and raised its price target to $16 from $10.
C3.Ai shares are climbing with conviction. Why is AI stock surging? Northland Says C3 Code Can Cut Agentic App Development From Months to DaysAccording to Investing.com, analyst Mike Latimore cited the company’s C3 Code platform as a new growth engine. He said it can reduce the time to create agentic AI applications to days from months and speeds up customer onboarding and expansion at existing customers. C3 Code lets users build and deploy applications using natural language, with autonomous agents handling the development work. It integrates with existing systems and builds on 15 years of C3 infrastructure work to keep applications reliable and secure.
C3.Ai also launched an Accelerator marketing program. The first event covered 110 people and 46 companies, and business and IT staff showed they could create enterprise-ready AI applications in a few days. The company has added three more Accelerator events. The upgrade also notes that C3.Ai’s founder and CEO rejoined the company in May, after challenges that included a reduction at a large customer, management changes and slower new customer additions about a year ago.
Recent Results and Other Analyst ViewsIn its first-quarter fiscal 2027 report, C3.Ai posted revenue of $52.4 million, down 25% from a year earlier. That was within its guidance range of $50.0 million to $54.0 million and slightly above the Street estimate of $52.1 million. Non-GAAP earnings per share were negative 20 cents, against the consensus estimate of negative 26 cents.
Other analysts have been more cautious. Yorkville Ives initiated coverage with an In Line rating and a $12.50 price target, noting that the fiscal 2026 reset is largely complete. Needham maintained a Hold rating, citing the revenue decline, and JMP Securities reiterated a Market Perform rating, citing concerns about revenue guidance.
Read Next
AI Price Action: At the time of publication, C3.Ai shares are trading 6.50% higher at $12.28, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
In the latest trading session, C3.ai, Inc. (AI - Free Report) closed at $11.53, marking a +1.68% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.6%. Elsewhere, the Dow gained 0.83%, while the tech-heavy Nasdaq added 0.64%.
Coming into today, shares of the company had gained 8.31% in the past month. In that same time, the Computer and Technology sector gained 4.03%, while the S&P 500 gained 1.34%.
The investment community will be paying close attention to the earnings performance of C3.ai, Inc. in its upcoming release. On that day, C3.ai, Inc. is projected to report earnings of -$0.22 per share, which would represent year-over-year growth of 12%. Meanwhile, our latest consensus estimate is calling for revenue of $53.1 million, down 29.34% from the prior-year quarter.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$0.76 per share and a revenue of $222.61 million, signifying shifts of +43.7% and -11.05%, respectively, from the last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for C3.ai, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.36% lower. C3.ai, Inc. presently features a Zacks Rank of #3 (Hold).
The Computers - IT Services industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 70, which puts it in the top 29% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
SummaryCompaniesQ3 earnings forecast to rise 31%: LSEGTech, top AI companies to drive growthJPMorgan, Goldman to report next weekNEW YORK, Oct 9 (Reuters) - US companies are likely to deliver another earnings surge for the third quarter, and like the rally in the stock market, AI-related players are fueling most of those gains.
While investors are enthusiastic about the hyper earnings growth fueled by AI companies, many are also worried about how long the trend can continue, and what will happen to share prices when it ends.
Sign up here.
Analysts on average expect S&P 500 earnings to rise about 31% year-over-year for the third quarter, with two-thirds of that leap coming from the technology sector and AI heavyweights Alphabet (GOOGL.O), opens new tab, Amazon.com (AMZN.O), opens new tab and Meta Platforms (META.O), opens new tab, according to Tajinder Dhillon, LSEG's head of earnings and equity research.
Tech share gains helped the S&P 500 (.SPX), opens new tab reach a record high this week ahead of the earnings season, which is expected to unofficially kick off next week with results from banks including JPMorgan Chase (JPM.N), opens new tab and Goldman Sachs (GS.N), opens new tab.
"It's all AI and, to a lesser extent, energy and materials, but that's because of geopolitics," said Sameer Samana, head of global equities and real assets at Wells Fargo Investment Institute. "It wouldn't surprise me if 70-80% of the growth can be attributed to tech and AI."
Energy (.SPNY), opens new tab earnings are seen up about 115% from a year ago, with US oil prices having surged roughly 30% in the third quarter because of the ongoing US-Israeli war with Iran.
"Almost as telling is if you look at the sectors that are not related to AI at all," Samana said, pointing to consumer staples (.SPLRCS), opens new tab and real estate (.SPLRCR), opens new tab, whose year-over-year earnings growth estimates for the third quarter are among the weakest.
Still, strategists are not sure if third-quarter earnings growth can surpass the banner growth of the second quarter. The majority of companies tend to beat analysts' estimates, and that is likely to be the case again in the third-quarter season.
Year-over-year S&P 500 earnings grew in the second quarter by nearly 54%, the highest since 2021, LSEG data showed. Excluding mark-to-market gains at Alphabet and Amazon.com on AI-related investments, that growth was about 35%, still the highest since 2021.
Letters spelling "AI," a keyboard and a robotic hand in this illustration created on September 23, 2026. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab
"A concern for investors is we are kind of approaching peak earnings growth" for the current cycle, said Anthony Saglimbene, chief market strategist at Ameriprise Financial. "A lot of this AI trade is built on continued capex spending, and every quarter we go, and they continue to spend, the hurdle rates get higher and the scrutiny gets larger."
Earnings for US semiconductor companies, among the biggest beneficiaries of the AI boom, are expected to have increased about 136% in the third quarter compared with about 158% in the second quarter, Dhillon said, based on LSEG data.
"Earnings estimate revision momentum is starting to cool," said Nick Raich, CEO of the Earnings Scout, an independent research firm.
"We're still going 100 miles an hour in the AI infrastructure buildout, but three months ago we were going 150 miles an hour."
Raich said the most recent reports including from Micron Technology (MU.O), opens new tab have been strong and suggest other companies are still "reaping the benefits."
Chipmaker Micron last month forecast quarterly revenue above estimates and said customers had increased commitments under its long-term supply agreements to $32 billion.
This week Google entered a massive power deal with Constellation Energy (CEG.O), opens new tab.
Investors are also likely to pay close attention this earnings season to how higher interest rates may be affecting corporate profits.
US bond yields have risen because of concerns about inflation, higher oil prices and debt problems in France and elsewhere.
Heavy borrowers, such as utilities (.SPLRCU), opens new tab, are at risk, Samana said.
Reporting by Caroline Valetkevitch; additional reporting by Noel Randewich in San Francisco; Editing by Nia Williams
Our Standards: The Thomson Reuters Trust Principles., opens new tab
[url="]bioAffinity Technologies[/url], Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company focused on the need for noninvasive tests for the detection of early-s
Next-Generation Cancer Immunotherapy Using Quantum Computing Selected for NEDO Demonstration Program
- A Joint R&D Project by NEC, Taiho Pharmaceutical, the Japanese Foundation for Cancer Research, AIST, and Waseda University
TOKYO, Oct 8, 2026 - (JCN Newswire) - A joint research and development project titled "Development and Demonstration of a Computational and Evaluation Platform for Next-Generation Cancer Immunotherapy Using Quantum Computing Technology," undertaken by NEC Corporation (NEC), Taiho Pharmaceutical Co., Ltd. (Taiho Pharmaceutical), the Japanese Foundation for Cancer Research (JFCR), the National Institute of Advanced Industrial Science and Technology (AIST), and Waseda University, has been selected for the Large-Scale Demonstration for Use Case Creation under the Research and Development Project of the Enhanced Infrastructures for Post-5G Information and Communication Systems administered by Japan's New Energy and Industrial Technology Development Organization (NEDO).
Under this project, the five organizations will integrate their respective technologies and expertise in quantum computing, artificial intelligence (AI), drug discovery, and immunology to establish a new computational and evaluation platform that enables the optimal design and immunological validation of neoantigen (*1) candidates, which are regarded as promising targets for cancer immunotherapy.
Background
Cancer immunotherapy, which harnesses the body's own immune system to eliminate cancer cells, has made significant advances in recent years. Among the most widely used approaches are immune checkpoint inhibitors, which enhance the immune response against tumors. However, not all patients derive sufficient benefit from these therapies, highlighting the need for new forms of cancer immunotherapy. Cancer immunotherapy targeting neoantigens that are present exclusively in cancer cells has emerged as a promising next-generation therapeutic approach for addressing this challenge.
Neoantigens, which arise specifically in cancer cells, are presented on the cell surface by major histocompatibility complex (MHC) molecules and can trigger antigen-specific immune responses. In particular, CD4-positive T-cell responses induced through MHC class II molecules (*2) are expected to play a pivotal role in activating other immune cells and sustaining immune responses, making them a key driver of potent and durable antitumor immunity.
However, the biological factors that govern MHC class II-mediated immune responses, including amino acid sequence characteristics, MHC class II binding, and cell surface presentation, remain highly complex and less understood. To date, no systematic methods have been established for designing and optimizing neoantigen sequences that induce CD4-positive T-cell responses via MHC class II while taking these multiple factors into account.
One of the key challenges lies in evaluating the vast number of possible amino acid sequence combinations, as well as the complex biological processes involved in antigen formation, presentation, and immune recognition. By applying quantum computing technology to this multifactorial sequence design and optimization challenge, the project aims to establish a new approach for exploring a broader design space and generating diverse neoantigen candidates with enhanced immunogenicity.
Project Overview
This project is scheduled to run from September 2026 to March 2029. It will serve as a drug discovery use case for applying quantum computing technology and AI to design and optimize neoantigen candidate sequences that induce CD4-positive T-cell responses through MHC class II.
The project will utilize AI to predict and score immune responses to neoantigen candidates, and apply quantum computing technology to the design of amino acid sequences flanking the neoantigen core region. Researchers will evaluate the potential of methods for designing diverse and promising sequence candidates from a vast number of sequence combinations while taking multiple factors into account, and the immune response generated by these optimized neoantigen sequences will then be evaluated through immunological experiments. By incorporating insights gained from these immunological experiments into computational models and AI-based prediction and evaluation methods, the project aims to establish a new drug discovery pipeline that integrates feedback between computational candidate design and experimental validation.
This project will utilize the ABCI-Q computing infrastructure-which integrates quantum computing, high-performance computing (HPC), and artificial intelligence (AI) being developed by the Global Research and Development Center for Business by Quantum-AI Technology (G-QuAT), AIST. Looking ahead, the companies aim to accelerate research and development of drug discovery innovations using quantum technologies originating in Japan.
(*1) Neoantigens are antigens generated by cancer-specific mutations. Since they are absent from normal tissues, neoantigens represent one of the most promising targets for cancer immunotherapy.(*2) In the immune system, MHC class II molecules bind antigenic peptides and transport them to the cell surface for presentation to CD4-positive T-cells.
About NEC
The NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group's approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.
For more information, please visit https://www.nec.com, and follow us on LinkedIn and YouTube.
Source: NEC Corporation
Copyright 2026 JCN Newswire . All rights reserved.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
AGCO Tech Day 2026 Spotlights Autonomy, AI and Mixed-Fleet Solutions to Enhance Farmer ProfitabilityPR Newswire
YORKVILLE, Ill., Oct. 5, 2026
, /PRNewswire/ -- AGCO (NYSE: AGCO) is demonstrating autonomy, artificial intelligence (AI) and mixed-fleet connectivity during its annual Tech Day at Stewart Farms near Yorkville, outside Chicago, Illinois. Showcased during the fall harvest, the technologies are designed to help farmers increase productivity, improve efficiency and enhance profitability across the crop cycle.
"Farmers judge technology by what it returns, not by what it promises," said Eric Hansotia, AGCO's Chairman, President and CEO. "At Tech Day, we are demonstrating autonomy, AI and connected solutions in the conditions farmers work in every day, helping them get more value from every pass across the field."
AGCO'sPTx® precision agriculture solutions are built to work across brands and machines and reach farmers through a dedicated technology channel designed to accelerate adoption. By combining specialized PTx dealers, AGCO machine dealers and OEM partnerships, AGCO can deliver retrofit and factory-fit solutions that help farmers connect mixed fleets, put their data to work and get more value from the equipment they already operate.
Throughout the event, AGCO will demonstrate how connected technologies work together from planning and planting through crop protection, harvest and service support:
Farm Management:PTxFarmENGAGE™ connects mixed fleets through a common digital platform, while the Panorama® intelligence platform transforms machine and agronomic data into actionable insights.Aurora™,AGCO's AI assistant that operates within Panorama, allowing farmers to ask questions using voice or text and quickly access the maps, reports and insights they need to make informed decisions.Planting: Momentum® planters, ArrowTube™ and Panorama work together to improve seed placement and support more consistent crop emergence.Weed Control: The FendtRogator® 900 equipped with AI-enabled SymphonyVision™ technology specifically targets only weeds with precision application capabilities designed to reduce chemical use and improve efficiency.Harvest Season: Harvest, grain handling, fertilizer application and tillage all land in the same six-to-eight-week window and finding labor to get them done on time is a challenge. At Tech Day, the Fendt IDEAL® combine runs alongside PTx's mixed-fleet retrofit autonomy solution, OutRun™ for tillage and in-field harvest logistics utilizing autonomous grain carts, with a FendtRogator applying next year's fertilizer behind the harvest so nutrients are incorporated before runoff losses can occur. The result is more jobs completed on schedule with the crew a farmer actually has.FarmerCore:AGCO's unique distribution service model combines over-the-air updates, remote diagnostics and expanded on-farm support to reduce downtime and bring expertise closer to farmers."Our Farmer-First strategy starts with giving farmers more choice in how they adopt technology," said Hansotia. "Whether through the equipment they already own, the brands they prefer or the dealer relationships they trust, AGCO is focused on making practical innovation easier to access and more valuable in the field."
The solutions demonstrated at Tech Day are commercially available today or progressing toward commercial availability. Farmers can learn more through their local Fendt®, Massey Ferguson®, Valtra®, or PTx dealer.
AGCO will host a presentation as part of Tech Day activities that updates the company's strategy and provides a detailed review of AGCO's precision ag business. The presentation on October 6 at 5:00 p.m. Central Time (CT) will feature Eric Hansotia, Chairman, President and Chief Executive Officer, and Damon Audia, President, PTx and Corporate Strategy. Investors may listen to a live webcast of the presentation by accessing the "Events and Presentations" section of the company's Investor Relations website at https://investors.agcocorp.com/events-and-presentations/upcoming-events. The webcast will also be archived immediately afterwards for 12 months.
Fendt, IDEAL, Massey Ferguson, Momentum, PTx, Rogator and Valtra are registered trademarks of AGCO. Aurora and OutRun are trademarks of AGCO. Panorama is a registered trademark of Precision Planting, LLC. ArrowTube, FarmENGAGE and SymphonyVision are trademarks of Precision Planting, LLC.
About AGCO
AGCO (NYSE: AGCO) is a global leader in agricultural machinery and precision agriculture technologies. Driven by a Farmer-First strategy, AGCO delivers value through its differentiated leading brands, Fendt™, Massey Ferguson™, PTx™ and Valtra™. AGCO's high-performance equipment and smart farming solutions, including brand-agnostic retrofit technologies and autonomous offerings, empower farmers to drive productivity while sustainably feeding the world. For more information, visit www.agcocorp.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/agco-tech-day-2026-spotlights-autonomy-ai-and-mixed-fleet-solutions-to-enhance-farmer-profitability-302897418.html
The Hackett Group, Inc. (NASDAQ: HCKT), an AI enterprise transformation firm, today announced findings from its 2026 North American Working Capital Survey, revealing that the 1,000 largest public companies in North America hold a record $1.94 trillion working capital management opportunity – up 12% from the prior year. The findings show that while companies delivered strong revenue growth, profitability and operating cash flow in 2025, significantly more cash became tied up in working capital, particularly in receivables.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005654787/en/
By most measures, the 1,000 largest North American public companies had a strong year. The Hackett Group’s 2026 North American Working Capital Survey found revenue up 6% to $17.6 trillion, while net income margin reached 10%. Operating cash flow rose to 17% of revenue and earnings before interest, taxes, depreciation and amortization (EBITDA) margin to 21% – each its strongest level in 13 years. Stronger profits came with more cash tied up for every dollar of revenue. The excess working capital opportunity climbed 12% to a record $1.94 trillion. The cash conversion cycle (CCC) shows how that deterioration stayed partially hidden. CCC improved by just 0.2 days, with the entire gain coming from one place. A 2.9-day improvement in days payable outstanding (DPO) narrowly offset deterioration in receivables (+2.1 days) and inventory (+0.6 days). Receivables are now the largest and fastest-growing component of the opportunity at $773 billion.
The survey found that revenue increased 6% to $17.6 trillion, operating cash flow reached a 13-year high at 17% of revenue and EBITDA (earnings before interest, taxes, depreciation and amortization) margins rose to 21%. Yet excess working capital relative to revenue increased, reversing three consecutive years of improvement and reaching its highest level on record.
“The headline numbers suggest many organizations had a very successful year, but a closer look shows a different story,” said Gerhard Urbasch, associate principal at The Hackett Group®. “Companies generated strong growth and profits, yet more cash became trapped in the processes that convert revenue into cash. Receivables have become the largest and fastest-growing source of working capital inefficiency, and the data shows that sustainable improvement requires a broader focus on how revenue becomes cash, not just isolated initiatives aimed at collections or payment terms.”
Although the overall cash conversion cycle (CCC) improved slightly, declining 0.2 days to 38.4 days, the improvement was driven entirely by stronger payables performance. Days sales outstanding (DSO) deteriorated sharply by 2.1 days, and days inventory outstanding (DIO) increased by 0.6 days, while days payable outstanding (DPO) improved by 2.9 days. As a result, gains in payables offset deterioration elsewhere in the cycle rather than reflecting broad-based improvement.
Receivables emerged as the largest and fastest-growing source of working capital inefficiency. The accounts receivable opportunity increased 29% year over year to $773 billion, representing 40% of the total working capital opportunity. DSO worsened for the third consecutive year and deteriorated in 40 of 50 industries analyzed. Aggregate receivables grew 11%, nearly twice the pace of revenue growth.
Receivables performance issues often originate long before an invoice becomes overdue. According to the survey, credit decisions, negotiated payment terms, order accuracy, billing quality, dispute management and cash application all influence how quickly revenue is converted into cash. The findings suggest that organizations taking an end-to-end process approach are better positioned to improve working capital performance than those focused solely on collections.
Inventory also contributed to the growing opportunity. The inventory opportunity rose 6% to $616 billion as organizations continued carrying buffer stock to manage tariff exposure, supply chain uncertainty and sourcing diversification efforts. The findings indicate many companies are prioritizing resilience and supply assurance, even when doing so increases balance sheet intensity.
Meanwhile, payables represented the strongest area of performance improvement. The payables opportunity remained relatively stable at $548 billion, while DPO reached its best level since 2021. Supply chain finance activity increased significantly, with settlement volumes rising 35% year over year. However, the report concludes that extending payment terms alone is unlikely to provide a sustainable path to future improvement.
The survey also highlights how difficult it is to sustain progress over time. Of the 1,000 companies analyzed, only 98 improved their cash conversion cycle for three consecutive years, just nine sustained improvement for five years and only two organizations achieved seven straight years of improvement.
According to The Hackett Group®, the findings underscore an emerging opportunity for process-led artificial intelligence (AI). The firm’s AI World Class benchmark research shows significantly stronger results among organizations that redesign workflows around AI-enabled decision-making, automation and exception handling. Compared with peers, AI World Class order-to-cash organizations demonstrate 138% more automated credit decisions, 134% greater digital order intake, 89% more automated cash application and 85% fewer delinquent days.
“The working capital challenge is increasingly becoming an AI opportunity,” said Kathleen Wiedeman, senior director at The Hackett Group®. “Leading organizations are not simply applying AI to existing processes. They are redesigning end-to-end workflows across order-to-cash, forecast-to-fulfill and purchase-to-pay. That’s where we see the greatest potential to improve cash flow, increase productivity and sustain performance gains over time.”
The Hackett Group’s 2026 North American Working Capital Survey analyzes the latest publicly available FY2025 financial results of the 1,000 largest nonfinancial companies headquartered in North America and evaluates performance across receivables, inventory and payables.
Download the full results and insights from the 2026 North American Working Capital Survey for free with registration.
About The Hackett Group®
The Hackett Group, Inc. (NASDAQ: HCKT) is an ROI-led, AI enterprise transformation firm that helps clients enable AI World Class performance. Its experts and engineers leverage Hackett AI platforms, including XT™, AIXelerator™, Hackett AI XPLR™, ZBrain® and XDA™, to accelerate and enhance the delivery of the company’s solutions and services.
The Hackett AI platforms are powered by the company’s domain-specific Solution Language Model informed by Hackett Process and Performance Intelligence, including Digital World Class® and AI World Class benchmark metrics, industry-specific best-practice process flows and service delivery model frameworks. The Hackett Group’s proprietary insights are based on benchmarking results from leading global organizations, including 98% of Dow Jones Global Titans, 97% of the Dow Jones Industrials and 90% of the Fortune 100. Visit www.thehackettgroup.com.
Trademarks
The Hackett Group®, quadrant logo, ZBrain® and Digital World Class® are the registered marks of The Hackett Group®.
This release contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements including without limitation, words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” or other similar phrases or variations of such words or similar expressions indicating, present or future anticipated or expected occurrences or outcomes are intended to identify such forward-looking statements. Forward-looking statements are not statements of historical fact and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. Factors that may impact such forward-looking statements include without limitation, the ability of The Hackett Group® to effectively market its digital transformation services, our ability to transition our capabilities to support generative artificial intelligence (AI)-related consulting services and solutions and other consulting services, our ability to effectively integrate acquisitions into our operations, our ability to manage joint ventures and successfully cooperate with our joint venture partners, competition from other consulting and technology companies that may have or develop in the future, similar offerings, the commercial viability of The Hackett Group® and its services as well as other risk detailed in The Hackett Group’s reports filed with the United States Securities and Exchange Commission. The Hackett Group® does not undertake any duty to update this release or any forward-looking statements contained herein.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261005654787/en/
Never has so much cash flowed into a new technology as is pouring into AI, eclipsing the sums splurged on railways or the internet when those technological revolutions sucked in capital.
Cumulative spending globally on data centers alone could top $30 trillion by 2050, according to a projection by PwC, almost matching the value of outstanding US Treasuries. It "dwarfs" what was spent in the railroad or dotcom booms, even after adjusting for inflation, PwC said.
Meanwhile, Anthropic, just one of the major firms in the AI race, plans to spend $518 billion in coming years, according to the IPO prospectus seen by Reuters, which is more than 100 times its 2025 revenue. Its backers say AI technology will be more transformational than the advent of steam engines and the industrialization they powered.
Yet lurking behind the dizzying projections and huge outlays by AI companies, alongside sky-high valuations, lie assumptions about vast broad-based productivity gains and future profits with little evidence so far - or historical precedent - to be sure they can deliver, economists say.
PRODUCTIVITY GAINS 'REMAIN ELUSIVE'
JP Morgan wrote in August that broad-based productivity gains in the US, which leads the AI race, "remain elusive", raising questions about the sustainability of AI valuations.
A Bain & Company study said productivity gains from existing markets would not be enough to justify current outlays and "entirely new markets must emerge to close the funding gap", suggesting those could range from using AI-guided robots to developing new materials for batteries and semiconductors.
US hyperscalers - the companies rolling out infrastructure around the world like Google, Amazon and Microsoft - and others in the AI race needed to find more than $4.2 trillion of new revenue in the next five years to fund the buildout, Bain said.
"The question is whether the applications arrive in time to pay for it," according to the study, published last month.
Few doubt the potential of AI to transform everything from work in an office to research labs, just as past revolutions shrank journey times from days to hours or connected the world at the touch of a keyboard.
What seems more immutable is the maths behind securing a return on investment or the deadlines for repaying loans, leaving economists to work out the implications for the global economy beyond the ups and downs of investment cycles.
"Historical precedent suggests that technology-driven booms often end when infrastructure buildouts cease to deliver sufficient returns," JP Morgan wrote.
Using the example of Nvidia, the US company whose chips are the backbone of the AI revolution, JP Morgan estimated US productivity gains would need to be 3% to 5% annually over the next 10 years to justify its valuation. That would be a substantial increase from the baseline expectation of the US Congressional Budget Office of 1.75% annual productivity growth for that period.
For the US alone - which according to some estimates accounts for about three quarters of the global AI investment total - investment will run as high as about $9 trillion from 2025 to 2032, equivalent to spending 3.2% of US GDP each year, according to Columbia Business School economist Stijn Van Nieuwerburgh.
He estimates the US AI sector would need to generate about $3.55 trillion in annual revenue by 2032 to earn a 10% return on investment. It earns a fraction of that now.
The leveraged structure of much of the debt funding AI infrastructure also means "a relatively modest deterioration in demand, delays, or asset values can therefore produce much larger losses," he wrote in a conference paper, revised in October.
AI AND 'THE RATE OF NEW WONDERS'
The dizzying numbers have not stopped US AI bosses speaking with an otherworldly zeal about changes afoot.
Anthropic's Dario Amodei has said an AI future could be "a thing of transcendent beauty", while OpenAI's Sam Altman has said "the rate of new wonders being achieved will be immense" as models learn to improve themselves and accelerate breakthroughs.
Jasjeet Sekhon, chief strategy officer at Google DeepMind, told a summit at UC Berkeley in August that this self-teaching, known as recursive self-improvement, was a "key part of the investment thesis", and that it could, if achieved, deliver unprecedented productivity gains.
Recursive self-improvement, while potentially delivering exponential AI advances, has also raised concerns about existential risks to humanity.
Yet the pace of change in productivity might still end up lagging the timelines needed by corporate accounts departments.
Diane Coyle, an economist at Britain's Cambridge University, said the productivity impact of past revolutionary technologies had usually taken about 10 to 50 years to feed through.
Anthropic's economics team modeled a range of scenarios for how much extra growth AI would deliver at an annual rate in 2030. Assuming a baseline of 2% in a non-AI environment, it suggested growth of 2.4% in a scenario with modest AI impact, 5.4% in a substantial scenario and 15.4% in an extreme scenario.
Higher growth would mean more jobs lost, it said, without assigning probabilities for any of the outcomes.
Amodei forecast last year that AI could wipe out half of all entry-level white-collar jobs within five years. For now, however, some researchers say it appears to have been limited to making it harder for those seeking office work to find a job.
Studies in the US and Britain have pointed to a slowdown in early career hiring for white-collar positions performing tasks at which AI is adept, even if overall employment remains strong.
Researchers at Stanford University said in August that employment of workers aged 22 to 25 in AI-exposed industries, such as accountants and paralegals, was 19% lower than for jobs that AI found hard to replicate, like janitors and builders.
Yet even if the promised transformation takes longer than numbers surrounding AI companies imply, real economic benefits should stay - just as trains still ran after the Panic of 1873 that bankrupted railroad barons, while the internet didn't shut down after the 1990s dotcom bubble burst.
"History is our friend in trying to understand this," said Coyle. "As long as one is left with the infrastructure that's needed to support all the productivity effects down the road, that's okay."
C3.ai, Inc. (NYSE:AI – Get Free Report)’s stock price was up 5.5% on Wednesday. The stock traded as high as $10.97 and last traded at $10.9120. Approximately 536,108 shares were traded during trading, a decline of 91% from the average daily volume of 5,945,981 shares. The stock had previously closed at $10.34.
Wall Street Analysts Forecast Growth Several analysts recently issued reports on the company. Citizens Jmp reiterated a “market perform” rating on shares of C3.ai in a report on Tuesday. Morgan Stanley boosted their price objective on C3.ai from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Thursday, June 4th. Needham & Company LLC reaffirmed a “hold” rating on shares of C3.ai in a research report on Thursday, September 3rd. Wedbush reaffirmed an “outperform” rating and issued a $15.00 target price on shares of C3.ai in a research report on Thursday, June 4th. Finally, Canaccord Genuity Group reiterated a “hold” rating and issued a $10.00 target price on shares of C3.ai in a research note on Thursday, September 3rd. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and seven have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and an average target price of $8.70.
Get Our Latest Report on AI
The firm’s 50 day moving average price is $10.22 and its two-hundred day moving average price is $9.59. The firm has a market capitalization of $1.78 billion, a PE ratio of -3.60 and a beta of 2.11. C3.ai (NYSE:AI – Get Free Report) last released its quarterly earnings results on Wednesday, September 2nd. The company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $0.06. C3.ai had a negative net margin of 192.10% and a negative return on equity of 61.25%. The firm had revenue of $52.38 million for the quarter, compared to the consensus estimate of $52.06 million. During the same quarter in the previous year, the firm posted ($0.37) EPS. The firm’s quarterly revenue was down 25.4% on a year-over-year basis. On average, sell-side analysts anticipate that C3.ai, Inc. will post -2.21 earnings per share for the current fiscal year.
Insider Transactions at C3.ai In other news, CFO Hitesh Lath sold 21,077 shares of C3.ai stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $10.48, for a total transaction of $220,886.96. Following the sale, the chief financial officer directly owned 371,036 shares of the company’s stock, valued at approximately $3,888,457.28. The trade was a 5.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Thomas Siebel sold 162,247 shares of the business’s stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $10.54, for a total value of $1,710,083.38. Following the completion of the transaction, the chief executive officer owned 722,362 shares in the company, valued at approximately $7,613,695.48. This trade represents a 18.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,117,809 shares of company stock worth $11,724,230. Corporate insiders own 19.80% of the company’s stock.
Hedge Funds Weigh In On C3.ai Institutional investors and hedge funds have recently made changes to their positions in the business. Sequoia Financial Advisors LLC acquired a new stake in shares of C3.ai during the second quarter worth approximately $106,000. Engineers Gate Manager LP bought a new position in C3.ai during the 2nd quarter valued at $2,855,000. Allworth Financial LP grew its holdings in C3.ai by 13.6% during the 2nd quarter. Allworth Financial LP now owns 26,660 shares of the company’s stock worth $242,000 after acquiring an additional 3,185 shares in the last quarter. Arizona State Retirement System grew its holdings in C3.ai by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 37,168 shares of the company’s stock worth $338,000 after acquiring an additional 1,310 shares in the last quarter. Finally, Nykredit A S bought a new stake in shares of C3.ai in the 2nd quarter worth about $84,000. 38.96% of the stock is currently owned by hedge funds and other institutional investors.
About C3.ai (Get Free Report)
C3.ai, Inc is an enterprise artificial intelligence software company that develops applications and tools designed to help organizations use AI and machine learning to analyze data, automate processes and support business decision-making. The company’s offerings are intended for large commercial enterprises, government agencies and other organizations managing complex operational and data environments.
Its product portfolio includes the C3 AI Platform, which provides capabilities for developing, deploying and operating AI applications, as well as prebuilt enterprise applications.
Further Reading Five stocks we like better than C3.ai Everyone in AI Is Quietly Copying Palantir’s Playbook Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next JPMorgan Bets on Genius Sports as the Market Loses Patience Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question Receive News & Ratings for C3.ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3.ai and related companies with MarketBeat.com's FREE daily email newsletter.
C3.ai, Inc. (AI - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this company have returned +1.9%, compared to the Zacks S&P 500 composite's +0.6% change. During this period, the Zacks Computers - IT Services industry, which C3.ai falls in, has lost 2.7%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, C3.ai is expected to post a loss of $0.22 per share, indicating a change of +12% from the year-ago quarter. The Zacks Consensus Estimate has changed +3.1% over the last 30 days.
The consensus earnings estimate of -$0.76 for the current fiscal year indicates a year-over-year change of +43.7%. This estimate has changed +3% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $0.46 indicates a change of +39.6% from what C3.ai is expected to report a year ago. Over the past month, the estimate has changed -8%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for C3.ai.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of C3.ai, the consensus sales estimate of $53.1 million for the current quarter points to a year-over-year change of -29.3%. The $222.61 million and $245.76 million estimates for the current and next fiscal years indicate changes of -11.1% and +10.4%, respectively.
Last Reported Results and Surprise HistoryC3.ai reported revenues of $52.38 million in the last reported quarter, representing a year-over-year change of -25.4%. EPS of -$0.2 for the same period compares with -$0.37 a year ago.
Compared to the Zacks Consensus Estimate of $51.46 million, the reported revenues represent a surprise of +1.79%. The EPS surprise was +23.08%.
Over the last four quarters, C3.ai surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
C3.ai is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about C3.ai. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
, /PRNewswire/ -- Nuix, a global leader in investigative analytics and intelligence software, was at Sibos 2026 in Miami, where the company showcased how its Nuix Neo platform helps financial institutions uncover financial crime, build evidence, defensibly support prosecution and enable justice from within complex, unstructured data.
Up to 90% of enterprise data is unstructured, including emails, documents, chat, counterparty data, transaction records, case files, and voice, that conventional systems cannot read, meaning critical risk signals could be missed. While the financial services industry continues to invest heavily in artificial intelligence (AI), Nuix is drawing attention to a more fundamental challenge: ensuring the data underpinning those investments is complete, accessible, reliable and connected.
"AI is only as good as the data beneath it, and in complex financial crime investigations seeing and connecting all evidence is critical," said Chris Stephenson, Head of Industry Advocacy at Nuix.
Nuix Neo is an integrated, AI-enabled, unstructured data intelligence platform with a patented data processing engine that can extract information from complex data, processing over 1,000 file types with forensic precision, at a binary level. Deterministic natural language processing classifies and risk scores the data, while the platform's semantic search capabilities surface relevant documents based on meaning and context, across languages. Each step in the workflow seamlessly filters, minimizes, curates and prioritizes the data to reduce manual data review and optimize investigative outcomes. Every action is recorded at the point of processing rather than reconstructed afterwards, so an institution can show a regulator, a Financial Intelligence Unit (FIU) or a court how a conclusion was reached.
Nuix has integrated decision intelligence and graph analytics capabilities from its acquisition of Linkurious, into Nuix Neo to help financial crime teams visualize relationships across accounts, people, organizations and transactions. This allows analysts to explore how those entities are connected and identify sophisticated patterns across complex networks at scale.
"Financial crime teams are not short of alerts; they are short of certainty. When data is fragmented, unstructured, and complex, the work becomes piecing it together with the wider context to build a full picture. We do that part, so the team's hours go to the risk that matters and the decision is explainable and defensible end to end," said Stephenson.
"Once you can see the network, you can investigate the risk in context," said Stephenson. "With Nuix Neo analysts can follow a counterparty across accounts, jurisdictions and years of transaction history, and then show a regulator exactly how they got there."
Financial crime compliance teams can investigate the counterparty relationships, transaction patterns and connections that can be difficult to identify through traditional tabular analysis. They can analyze multi-hop relationships, overlay external enrichment sources and corporate registries to uncover sophisticated criminal schemes. Analysts can triage with confidence, and years of historical transaction data can be reprocessed to surface patterns earlier models missed.
Explainable, Defensible AI
Nuix Neo's responsible AI architecture incorporates deterministic scoring to drive explainable, auditable, and defensible outcomes. Organizations can also connect their own approved large language models with Nuix Neo's BYO-AI capability, maintaining data sovereignty and audit trails. As with any Gen AI capability, outputs remain probabilistic and must be verified against source material and are intended to support, not replace, the judgment of qualified investigators, analysts, reviewers, and legal professionals.
About Nuix
Nuix is a leading provider of investigative analytics and intelligence software, that empowers customers to be a force for good by finding truth in the digital world. We help customers collect, process and review large amounts of structured and unstructured data, making it searchable and actionable at scale and speed, with forensic accuracy.
For further information, please visit nuix.com
View original content:https://www.prnewswire.com/news-releases/nuix-takes-to-sibos-2026-to-help-financial-institutions-turn-complex-data-into-financial-crime-intelligence-302896828.html
Senator Ted Budd, Republican from North Carolina, joined Balance of Power to discuss the Senate's last day in session before midterms. He also discussed recent news from the Fed and how the US must stay ahead of China when it comes to AI.
Atrium Mortgage Investment Co. (TSE:AI – Get Free Report)’s share price passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of C$11.75 and traded as low as C$11.38. Atrium Mortgage Investment shares last traded at C$11.44, with a volume of 83,185 shares traded.
Wall Street Analysts Forecast Growth Separately, Fundamental Research set a C$12.82 price objective on Atrium Mortgage Investment and gave the company a “buy” rating in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Strong Buy” and a consensus price target of C$13.16.
View Our Latest Report on Atrium Mortgage Investment
Atrium Mortgage Investment Price Performance The company has a 50 day simple moving average of C$11.56 and a 200 day simple moving average of C$11.75. The company has a market capitalization of C$553.08 million, a price-to-earnings ratio of 11.56 and a beta of 0.67. The company has a quick ratio of 102.54, a current ratio of 3.72 and a debt-to-equity ratio of 55.94. Atrium Mortgage Investment Announces Dividend The company also recently disclosed a monthly dividend, which was paid on Wednesday, August 12th. Shareholders of record on Wednesday, August 12th were given a $0.0775 dividend. The ex-dividend date of this dividend was Friday, July 31st. This represents a $0.93 annualized dividend and a yield of 8.1%. Atrium Mortgage Investment’s dividend payout ratio (DPR) is 93.94%.
Atrium Mortgage Investment Company Profile (Get Free Report)
Atrium is a non-bank provider of residential and commercial mortgages that lends in major urban centres in Canada where the stability and liquidity of real estate are high. Atrium’s objectives are to provide its shareholders with stable and secure dividends and preserve shareholders’ equity by lending within conservative risk parameters. Atrium is a Mortgage Investment Corporation (‘MIC’) as defined in the Canada Income Tax Act, so is not taxed on income provided that its taxable income is paid to its shareholders in the form of dividends within 90 days after December 31 each year.
Read More Five stocks we like better than Atrium Mortgage Investment CarMax Just Gave Investors a Better Reason to Believe in the Turnaround CoreWeave Comes With Risks: Analysts Split on What Matters Most Bottlenecking the Future: TSMC Prices Out the Competition Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock? Receive News & Ratings for Atrium Mortgage Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrium Mortgage Investment and related companies with MarketBeat.com's FREE daily email newsletter.
Capstone Partners Releases 2026 Middle Market Business Owners Research Survey: CEOs Acclimate to Volatility and Exhibit Optimism, Exit Preparation Bolsters Deci
, /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directors, Mr. Jian Sun, who is the chairman of the Special Committee, Mr. Nee Chuan Teo and Mr. Jun Luo, has been established by the Company's Board of Directors to consider and evaluate the previously announced preliminary, non-binding proposal letter dated September 16, 2026 (the "Proposal") as well as other potential strategic alternatives that the Company may pursue.
The Board cautions the Company's shareholders and others considering trading the Company's securities that no decisions have been made with respect to the Proposal or any alternative strategic option that the Company may pursue. There can be no assurance that any definitive offer will be received, that any definitive agreement will be executed relating to the transaction contemplated by the Proposal or that any other comparable transaction will be approved or consummated. The Company does not undertake any obligation to provide any updates with respect to any transaction, except as required under applicable law.
Forward-Looking Statements
This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident" and similar statements. Among other things, the Business Outlook and quotations from management in this announcement, as well as 111's strategic and operational plans, contain forward-looking statements. 111 may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control. Forward-looking statements involve inherent risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. Potential risks and uncertainties include, but are not limited to, uncertainties as to the Company's ability comply with extensive and evolving regulatory requirements, its ability to compete effectively in the evolving PRC general health and wellness market, its ability to manage the growth of its business and expansion plans, its ability to achieve or maintain profitability in the future, its ability to control the risks associated with its pharmaceutical retail and wholesale businesses, and the Company's ability to meet the standards necessary to maintain listing of its ADSs on the Nasdaq Global Market, including its ability to cure any non-compliance with Nasdaq's continued listing criteria. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and 111 does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
About 111
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading technology-enabled healthcare platform transforming China's healthcare value chain through digitalization and artificial intelligence (AI). By connecting consumers, pharmacies, pharmaceutical companies and other healthcare participants, 111 aims to make pharmaceutical products and healthcare services more accessible, efficient and affordable, while helping industry participants operate more intelligently.
Through its integrated ecosystem, 1 Pharmacy, the Company's online retail pharmacy, provides consumers with convenient access to a broad range of pharmaceutical products and healthcare services. On the B2B side, 1 Medicine offers pharmacies a one-stop digital sourcing platform, helping them improve purchasing efficiency, product availability and inventory management. Leveraging its pharmacy network, proprietary industry data and digital infrastructure, 111 is increasingly deploying AI-powered solutions and Agents to help pharmacies manage daily operations, including sales analysis, inventory optimization, replenishment, pricing and promotions. For pharmaceutical and healthcare companies, 111 provides an omni-channel commercialization platform combining digital marketing, patient education, data analytics, pricing and market monitoring.
111 is transforming from a digital company into an AI-powered healthcare company. Using its industry data and digital capabilities, the Company deploys AI Agents that move beyond information and analysis to execute workflows for pharmacies and other industry participants. With AI models, proprietary healthcare data and interconnected business systems, 111 aims to build an intelligent operating layer for healthcare and strengthen its role as a tech platform linking China's healthcare value chain upstream and downstream.
For more information on 111, please visit: http://ir.111.com.cn/.
For more information, please contact:
111, Inc.
Investor Relations
Email: [email protected]
111, Inc.
Media Relations
Email: [email protected]
Phone: +86-021-2053 6666 (China)
View original content:https://www.prnewswire.com/news-releases/111-inc-announces-establishment-of-the-special-committee-302891226.html
Experian® today released its 2027 Data Breach Industry Forecast: Consumers at Risk, offering a look at the evolving cybersecurity landscape and the growing risks facing consumers and organizations in the years ahead. Now in its 14th year, the annual report explores how artificial intelligence (AI), identity fraud, data breaches and digital deception are converging to create what may become one of the biggest cybersecurity challenges of next year and beyond: a crisis of trust.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260928753555/en/
Experian® today released its 2027 Data Breach Industry Forecast: Consumers at Risk, offering a look at the evolving cybersecurity landscape and the growing risks facing consumers and organizations in the years ahead.
As cybercriminals gain access to decades of stolen personal data and increasingly powerful AI tools, businesses may find it harder than ever to verify identities online to combat fraud. At the same time, consumers may face increasing difficulty distinguishing legitimate communications from fraudulent ones and preventing identity doppelgängers. The report examines how these trends could transform the relationship between businesses, consumers and digital trust.
"Organizations have spent years focusing on preventing breaches and securing data. But with decades of exposed data already circulating the focus also needs to be on verification practices, combatting fraud and helping consumers determine what and who they can trust," said Michael Bruemmer, Vice President of Global Data Breach Resolution at Experian. "Cybersecurity is entering a new era where proving authenticity is just as important as protecting data and Experian can help with leading verification and fraud prevention services as well as providing post-incident response support. Businesses that prepare now will be in a stronger position to navigate the evolving threat landscape and maintain customer confidence."
Emerging Trends That Could Shape 2027
The forecast outlines four predictions that examine potential changes and risks on the horizon, including:
Proof of Being Human Becomes the Hottest New Market: The rise of technologies and services designed to help organizations and consumers verify authenticity in an AI-driven world.The Rise of the Digital Doppelgänger: The evolution of identity theft as cybercriminals build increasingly sophisticated and convincing profiles of individuals.Consumers Fighting Fire with Fire: New ways consumers may attempt to protect themselves from identity theft as the number of data breaches continues to climb.Breach Notifications Need a Reset: How growing skepticism toward digital communications could influence regulatory mandates and future data breach notification practices.Read the full predictions and download the complimentary 2027 Data Breach Industry Forecast, here: https://us-go.experian.com/data-breach-industry-forecast.
Experian Data Breach Resolution helps organizations respond quickly and confidently to data breaches with over 24 years of crisis-management experience. The company's services include breach preparedness, consumer notification, contact center support, identity protection services and global response capabilities designed to help organizations protect customer trust and reduce reputational risk.
For more information about Experian Global Data Breach Resolution, visit: https://www.experian.com/business/solutions/fraud-management/global-data-breach-services.
About Experian
Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and platforms. We also assist millions of people to realise their financial goals and help them to save time and money.
We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.
We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260928753555/en/
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Thomas M. Siebel, Chief Executive Officer and Chairman of the Board at C3.ai, Inc. (AI -1.02%), executed a sale of 444,248 shares of Class A Common Stock on September 15, 2026 and September 16, 2026, according to a recent SEC Form 4 filing.
Transaction summaryMetricValueTransaction value~$4.8 millionShares sold444,248Post-transaction shares (directly held)722,362Post-transaction shares (indirectly held)~8.6 millionPost-transaction value$98.38 millionTransaction value based on SEC Form 4 weighted average sale price ($10.77); post-transaction value based on September 16, 2026 market close ($10.56).
Key questionsWhat was the structural nature of this disposition?
The transaction was a cashless exercise and sale involving 444,248 options with a strike price of $3.90, which were converted to Class A Common Stock and immediately sold on the open market.How much direct equity does the insider retain?
Following this transaction, Siebel holds 722,362 shares directly and ~2.1 million derivative securities, which include both vested and unvested awards.Which entities facilitate the insider's indirect ownership?
The indirect position is distributed across several legal entities, with the largest concentration in The Siebel Living Trust, which holds 7,105,019 shares, followed by The Siebel 2011 Irrevocable Children's Trust with ~1.2 million shares.What is the current valuation context for the stock?
As of the September 17, 2026 market close, the stock was priced at $10.78, following a -40% one-year total return as of the September 16, 2026 transaction date.Company OverviewMetricValueShare Price (as of market close 2026-09-17)$10.78Market Capitalization$1.6 billionRevenue (TTM)$232.4 millionNet Income (TTM)-$446.4 millionCompany SnapshotC3.ai provides enterprise artificial intelligence software solutions, with primary revenue derived from its C3 AI Application Platform, a comprehensive environment for developing, deploying, and operating enterprise-scale AI applications, supplemented by specialized tools including C3 AI Ex Machina for data preparation and C3 AI CRM for customer relationship management.The company operates on a software-as-a-service (SaaS) business model, generating revenue through licensing fees and subscription arrangements for its AI platform and specialized applications to enterprise customers globally.C3.ai serves large-scale enterprises across North America, Europe, the Middle East, Africa, and the Asia Pacific region, targeting organizations seeking to develop and deploy mission-critical artificial intelligence applications at scale.C3.ai is a leading provider of enterprise AI software solutions with a global footprint spanning multiple regions and a workforce of 764 employees. The company has established itself as a significant player in the enterprise AI application platform market, with TTM revenues of $232.4 million and a market cap of $1.6 billion.
C3.ai's competitive differentiation centers on its comprehensive platform approach, enabling enterprises to accelerate AI development and deployment cycles while reducing time-to-value for artificial intelligence initiatives.
What this transaction means for investorsThe sale of C3.ai stock on September 15 and 16 by CEO Thomas Siebel took place after shares had fallen 40% in the past year. However, this was not a market-timed investment decision.
Rather, it was a non-discretionary transaction executed as part of a pre-established Rule 10b5-1 plan. Such plans allow insiders to sell shares at predetermined times to avoid concerns of trading on non-public information.
Post-disposition, Siebel continues to maintain millions of shares. This substantial equity position in C3.ai ensures his continued alignment with shareholder interests.
Shares of the company Siebel founded have plunged over the past year because the CEO had to step away from his role in 2025 due to health concerns. He returned to the position in June, but in the interim, C3.ai fell on hard times.
With Siebel back at the helm, the company reported a 73% quarter-over-quarter increase in customer bookings, a sign that business is ramping back up.
Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, today announced internal leader
Kforce Inc. (NYSE: KFRC), a solutions firm that specializes in technology and other professional staffing services, today announced that management will partici
Basecamp Research said on Wednesday it has raised $140 million in a Series C funding round that valued the AI-based drug developer at $800 million.
The oversubscribed round was led by S32, with participation from Nvidia (NVDA.O), Anthropic's Anthology Fund, Catalio Capital Management, the NATO Innovation Fund, the Rockefeller Foundation and Singular, among other investors.
Basecamp raised $60 million in its Series B round in October 2024, led by Singular.
The company said it would use the latest funding to train a new generation of its EDEN biological foundation models and move a pipeline of AI-designed therapies toward clinical development.
The London-based company will initially focus on therapies that reprogram patients' cells inside the body.
The company said its EDEN technology could make cell therapies more customizable and easier to administer for cancer and autoimmune diseases, compared to current treatments that it said cost "hundreds of thousands of dollars per patient".
Basecamp added it had demonstrated strong preclinical results across several types of therapies and diseases, but did not provide a timeline for starting clinical trials.
EDEN is trained on Basecamp's proprietary genomic dataset, assembled through partnerships in more than 30 countries, and can generate potential drug candidates based on information about a disease, the company said.
The company also appointed former Biogen (BIIB.O) executive Richard Pearce as chief business officer to expand its pharmaceutical partnerships.
C3.ai, Inc. (AI - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of this company have returned +1.8% over the past month versus the Zacks S&P 500 composite's -1.3% change. The Zacks Computers - IT Services industry, to which C3.ai belongs, has gained 0.8% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, C3.ai is expected to post a loss of $0.22 per share, indicating a change of +12% from the year-ago quarter. The Zacks Consensus Estimate has changed +3.3% over the last 30 days.
For the current fiscal year, the consensus earnings estimate of -$0.77 points to a change of +43% from the prior year. Over the last 30 days, this estimate has changed +2.3%.
For the next fiscal year, the consensus earnings estimate of $0.48 indicates a change of +38.2% from what C3.ai is expected to report a year ago. Over the past month, the estimate has changed -4%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for C3.ai.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For C3.ai, the consensus sales estimate for the current quarter of $53.1 million indicates a year-over-year change of -29.4%. For the current and next fiscal years, $223.01 million and $247.31 million estimates indicate -10.9% and +10.9% changes, respectively.
Last Reported Results and Surprise HistoryC3.ai reported revenues of $52.38 million in the last reported quarter, representing a year-over-year change of -25.4%. EPS of -$0.2 for the same period compares with -$0.37 a year ago.
Compared to the Zacks Consensus Estimate of $51.46 million, the reported revenues represent a surprise of +1.79%. The EPS surprise was +23.08%.
Over the last four quarters, C3.ai surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
C3.ai is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about C3.ai. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
CXMT's latest DRAM expansion raises a longer-term question for two major beneficiaries of the AI memory boom. Summary
China’s CXMT has started mass production of fifth-generation DRAM
For instance, Micron Technology Inc. (MU, Financials) makes memory chips for AI and data-center applications, offering DRAM and high-bandwidth memory, and it is confronting a new competitive development out of China.
ChangXin Memory Technologies, or CXMT, has begun mass production of its fifth-generation DRAM platform, which it says can yield at least 50% more dies per wafer than its previous iteration. CXMT has announced two 24-gigabit LPDDR5X processors for cellphones and other portable devices .
The advancement may put pressure on Micron and SK Hynix in conventional DRAM. According to TrendForce, CXMT had 9.5% of worldwide DRAM revenue in the second quarter of 2026, compared to 23.3% for Micron and 24.9% for SK Hynix.
The overlap between the two seems minimal for now. CXMT's recent products are mostly targeted at mobile and traditional DRAM, whereas Micron and SK Hynix have been transitioning more capacity to HBM and high-capacity server memory utilized in artificial intelligence (AI) systems.
And that distinction counts. If CXMT moves beyond mobile DRAM into server memory and more advanced products, that would pose a bigger risk to the two firms.
According to TipRanks, analysts see upside potential of 54.01% for Micron and 33.17% for SK Hynix, reflecting continued bullish sentiment on Wall Street for both stocks.
The next question for investors is whether CXMT can translate better wafer efficiency into a wider challenge to the global memory giants.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Solidion Technology Board Appoints Jaymes Winters as Chairman and CEO; Mark Schwartz as Lead Independent DirectorPR NewswireDALLAS, Sept. 20, 2026New Designatio
C3.ai, Inc. (NYSE:AI – Get Free Report) CFO Hitesh Lath sold 21,077 shares of C3.ai stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $10.48, for a total value of $220,886.96. Following the sale, the chief financial officer owned 371,036 shares in the company, valued at $3,888,457.28. This trade represents a 5.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Hitesh Lath also recently made the following trade(s):
On Tuesday, August 4th, Hitesh Lath sold 20,000 shares of C3.ai stock. The shares were sold at an average price of $10.00, for a total value of $200,000.00. On Tuesday, June 30th, Hitesh Lath sold 48,619 shares of C3.ai stock. The stock was sold at an average price of $8.77, for a total value of $426,388.63. C3.ai Stock Down 2.7% AI opened at $10.49 on Friday. C3.ai, Inc. has a 52 week low of $7.68 and a 52 week high of $20.22. The business’s 50 day moving average is $9.86 and its two-hundred day moving average is $9.48. The firm has a market cap of $1.63 billion, a price-to-earnings ratio of -3.41 and a beta of 2.10.
C3.ai (NYSE:AI – Get Free Report) last announced its earnings results on Wednesday, September 2nd. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.06. C3.ai had a negative net margin of 192.10% and a negative return on equity of 61.25%. The business had revenue of $52.38 million for the quarter, compared to analyst estimates of $52.06 million. During the same period last year, the firm posted ($0.37) earnings per share. The company’s revenue for the quarter was down 25.4% compared to the same quarter last year. Equities analysts expect that C3.ai, Inc. will post -2.22 EPS for the current fiscal year. Institutional Trading of C3.ai Several hedge funds and other institutional investors have recently made changes to their positions in AI. Bank of America Corp DE increased its holdings in C3.ai by 55.1% in the first quarter. Bank of America Corp DE now owns 3,282,183 shares of the company’s stock valued at $27,636,000 after buying an additional 1,166,302 shares in the last quarter. First Trust Advisors LP lifted its position in shares of C3.ai by 67.3% during the 1st quarter. First Trust Advisors LP now owns 1,215,341 shares of the company’s stock valued at $10,233,000 after acquiring an additional 488,710 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of C3.ai by 0.8% during the 1st quarter. Bank of New York Mellon Corp now owns 690,694 shares of the company’s stock worth $5,816,000 after acquiring an additional 5,631 shares in the last quarter. Edgestream Partners L.P. grew its holdings in shares of C3.ai by 247.5% in the 1st quarter. Edgestream Partners L.P. now owns 658,573 shares of the company’s stock worth $5,545,000 after acquiring an additional 469,057 shares during the period. Finally, EVR Research LP grew its holdings in shares of C3.ai by 223.8% in the 4th quarter. EVR Research LP now owns 600,400 shares of the company’s stock worth $8,093,000 after acquiring an additional 415,000 shares during the period. Institutional investors and hedge funds own 38.96% of the company’s stock.
Analysts Set New Price Targets A number of equities analysts recently issued reports on the company. Wedbush reissued an “outperform” rating and set a $15.00 price target on shares of C3.ai in a report on Thursday, June 4th. Canaccord Genuity Group reaffirmed a “hold” rating and set a $10.00 price objective on shares of C3.ai in a research note on Thursday, September 3rd. KeyCorp reiterated an “underweight” rating on shares of C3.ai in a research note on Thursday, June 4th. Citizens Jmp reissued a “market perform” rating on shares of C3.ai in a report on Thursday, September 3rd. Finally, DA Davidson restated an “underperform” rating and set a $7.00 price target on shares of C3.ai in a research note on Tuesday, September 1st. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and seven have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average target price of $8.70.
Read Our Latest Research Report on AI
About C3.ai (Get Free Report)
C3.ai, Inc develops enterprise artificial intelligence software and applications for organizations in a range of industries. Its technology is designed to help businesses use data, machine learning and predictive analytics to address operational, financial and strategic challenges.
The company’s offerings include the C3 AI Platform, which provides tools for developing, deploying and operating AI applications, as well as prebuilt applications for use cases such as predictive maintenance, fraud detection, supply-chain optimization, customer engagement, energy management and regulatory compliance.
See Also Five stocks we like better than C3.ai Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. Housing Priced for a Pullback or More Gains? These 3 Stocks Are Testing the Limits These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
Receive News & Ratings for C3.ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3.ai and related companies with MarketBeat.com's FREE daily email newsletter.
Thomas M. Siebel, CEO and Chairman of the Board of C3.ai, Inc. (AI -2.13%), disposed of 66,752 shares of Class A Common Stock on Sept. 14, 2026, according to a recent SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$705,000Shares sold22,780Shares gifted43,972Shares gifted (directly held)21,986Shares gifted (indirectly held)21,986Post-transaction shares (directly held)~722,000Post-transaction shares (indirectly held)~8.6 millionPost-transaction value$104.1 millionTransaction value based on SEC Form 4 weighted average sale price ($10.56); post-transaction value based on Sept. 14, 2026 market close ($11.17).
Key questionsWhat triggered this specific disposal of shares?
The disposition was non-discretionary, occurring automatically under company policy to satisfy tax withholding requirements following the vesting of restricted stock units (RSUs) on Sept. 11, 2025, and subsequent quarterly vesting periods.How are the remaining indirect holdings distributed?
The CEO controls approximately 8.6 million shares held indirectly through several entities, with the largest portions managed by The Siebel Living Trust (~7.1 million shares) and The Siebel 2011 Irrevocable Children's Trust (~1.2 million shares).What is the status of the insider's total equity exposure?
Despite the recent disposal, Thomas M. Siebel remains a significant stakeholder with 9.3 million shares of Class A Common Stock and an additional 179,228 direct derivative securities, representing a total beneficial ownership value of approximately $104.1 million as of the Sept. 14, 2026 market close.How has the stock performed leading up to this transaction?
At the time of the transaction on Sept. 14, 2026, shares were priced at $11.17 at the market close, reflecting a one-year total return of -38%.Company OverviewMetricValueShare Price (as of market close 2026-09-15)$10.79Market Capitalization$1.70 billionRevenue (TTM)$232.40 millionNet Income (TTM)-$446.40 millionCompany SnapshotC3.ai provides enterprise artificial intelligence software solutions, with core offerings including the C3 AI Application Platform for developing and deploying enterprise-scale AI applications, complemented by specialized tools such as C3 AI Ex Machina for data preparation and C3 AI CRM for customer relationship management.The company generates revenue through licensing its AI software platform and related applications to enterprise customers globally, enabling organizations to build, deploy, and operate AI-driven business solutions at scale.C3.ai serves a diverse customer base across North America, Europe, the Middle East, Africa, and the Asia Pacific region, targeting large enterprises seeking to implement artificial intelligence capabilities across their operations.C3.ai is a leading provider of enterprise AI software with a market capitalization of $1.70 billion and TTM revenues of $232.40 million. The company operates with 764 employees and maintains a global presence across multiple geographic regions. C3.ai's competitive advantage lies in its comprehensive AI application platform that enables enterprises to rapidly develop and deploy AI solutions without requiring extensive in-house AI expertise.
What this transaction means for investorsIt is always notable when a CEO sells company shares, and Thomas Siebel's sale of C3.ai shares is no exception.
However, the disposition of the 66,752 shares occurred automatically to satisfy tax withholding requirements, meaning it would have happened regardless of the SaaS stock's performance. Hence, Siebel's sale is probably not a cause for concern.
Nonetheless, other factors give investors little reason for optimism, besides the 38% stock price decline over the last year.
Premium Feature
Moneyball Superscore
38/100
Today's Change
(
-2.13
%) $
-0.23
Current Price
$
10.56
AI has driven massive gains in many of the more prominent stocks, but that does not seem to be the case with C3.ai. In the first quarter of fiscal 2027 (ended July 31), revenue fell by 26% to $52 million. Also, even though losses fell over that period, the $93 million lost exceeded its revenue.
C3.ai is in the middle of a transition to a subscription-based model, likely influencing the revenue decline. Also, the company seems to have lost ground to cloud providers and competitors like Palantir, which may also weigh on revenues.
Still, while these issues have created tremendous uncertainty that may dissuade investors from owning the stock, Siebel's stock sale is probably not one of those concerns.
Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool recommends C3.ai. The Motley Fool has a disclosure policy.
Global asset managers are concentrating resources on core capabilities, accelerating outsourcing of non-core activities, tightening cost controls and expanding
'The Big Money Show' panel discusses AI fears and says they are 'designed to scare' the public, according to former White House AI czar David Sacks. FOX Business' Dagen McDowell argues that the media had responsibility in this AI fear.
Are you looking for pure-play exposure to artificial intelligence or a proven software giant? Comparing C3.ai (AI +0.34%) and Atlassian (TEAM +2.12%) reveals two very different paths for software investors today.
C3.ai specializes in enterprise AI applications for complex industries like defense and energy. Atlassian provides the essential collaboration tools that software teams use daily. While both companies operate in the tech stocks space, they offer different levels of maturity and financial stability.
The case for C3.aiC3.ai sells pre-built AI applications that help organizations improve efficiency in sectors like manufacturing and utilities. It works with major partners like Baker Hughes (BKR -6.86%) and Microsoft (MSFT +0.17%). Customer concentration like this adds a layer of risk to the business since a few partners represent a large revenue share.
In FY 2026, revenue reached nearly $250.3 million, a decrease of approximately 35.7% from the prior year. This drop contributed to a net loss of roughly $470.4 million for the period. The net margin for the year was nearly -187.9%, which indicates that expenses were significantly higher than sales.
As of its April 2026 balance sheet, the debt-to-equity ratio is 0.0x, meaning the company has no debt relative to its equity. The current ratio stands at nearly 6.6x, meaning it has over six times more current assets than current liabilities. Free cash flow, which is cash from operations minus capital expenditures, was a loss of roughly $190.7 million.
The case for AtlassianAtlassian builds tools like Jira and Confluence that help over 350,000 organizations manage their workflow. It serves over 85% of the Fortune 500 through a low-touch sales model that focuses on organic adoption. The company is currently transitioning users from older server-based products to its modern cloud platform.
In FY 2026, revenue reached close to $6.6 billion, marking growth of approximately 26% year over year. Despite the sales growth, the company reported a net loss of nearly $53.8 million. Its net margin improved to roughly -0.8%, which is a narrow loss relative to its total sales.
On its June 2026 balance sheet, the debt-to-equity ratio was nearly 1.2x, while the current ratio of 0.8x suggests liabilities exceed current assets. Free cash flow, which is cash from operations minus capital expenditures, reached roughly $1.3 billion. Note that stock-based compensation represented roughly 118.7% of operating cash flow, meaning reported cash generation is heavily inflated by this non-cash add-back.
Risk profile comparisonC3.ai faces risks from persistent operating losses and an accumulated deficit that reached $1.8 billion in early 2026. It relies heavily on a limited number of enterprise customers and faces competition from Microsoft and Amazon (AMZN -0.04%). The complexity of its AI can also lead to issues with bias or technical hallucinations.
Atlassian faces competition in the collaboration market from Microsoft, Salesforce (CRM -0.19%), and Workday (WDAY -0.75%). Its transition to cloud offerings may lead to higher hosting costs or customer losses if migration challenges persist. Additionally, the dual-class voting structure gives the co-founders significant control over corporate decisions.
Valuation comparisonMetricC3.aiAtlassianForward P/EN/A36.0xP/S ratio6.5x7.9xValuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
I'd go with Atlassian, and it's not even close. Its most recent quarter was an absolute breakout: Cloud revenue accelerated, the company returned to GAAP profitability for the first time in years, and earnings beat estimates by a wide margin. Enterprises are signing larger, longer deals, and its AI tools are gaining traction in ways that are showing up directly in customer spending. The stock surged after results for good reason.
Management's forecast for next year looks conservative, but it's largely because a surge in older product sales that inflated this year's results won't be repeated. The cloud business that actually drives long-term growth continues to move in the right direction.
C3.ai, by contrast, is in the middle of a painful reset. Its own CEO called recent sales results "unspeakably horrible," the company cut roughly a third of its workforce, and revenue has been falling. A full sales reorganization is underway, but turnarounds of this magnitude take time.
For a long-term investor, the choice here comes down to a company that has already done the hard work of restructuring and is now accelerating, versus one that is still trying to figure out where the bottom is.
C3.ai, Inc. (AI - Free Report) reported $52.38 million in revenue for the quarter ended July 2026, representing a year-over-year decline of 25.5%. EPS of -$0.20 for the same period compares to -$0.37 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $51.46 million, representing a surprise of +1.79%. The company delivered an EPS surprise of +23.08%, with the consensus EPS estimate being -$0.26.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how C3.ai performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Gross margin- Professional services: 69% compared to the 51.7% average estimate based on three analysts.Gross margin- Subscription: 29% versus the three-analyst average estimate of 27.9%.Revenue- Professional services: $3.21 million compared to the $3.07 million average estimate based on five analysts. The reported number represents a change of -67.8% year over year.Revenue- Subscription: $49.17 million compared to the $48.28 million average estimate based on five analysts. The reported number represents a change of -18.5% year over year.View all Key Company Metrics for C3.ai here>>>
Shares of C3.ai have returned +3% over the past month versus the Zacks S&P 500 composite's -1.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
[url="]Cognyte Software Ltd.[/url] (NASDAQ: CGNT) (the âCompany,â âCognyte,â âwe,â âusâ and âourâ), a global leader in AI-powered investigat
C3.ai, Inc. (AI - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this company have returned +0.6%, compared to the Zacks S&P 500 composite's -0.4% change. During this period, the Zacks Computers - IT Services industry, which C3.ai falls in, has gained 4.6%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, C3.ai is expected to post a loss of $0.22 per share, indicating a change of +12% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
The consensus earnings estimate of -$0.82 for the current fiscal year indicates a year-over-year change of +39.3%. This estimate has remained unchanged over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $0.49 indicates a change of +39.7% from what C3.ai is expected to report a year ago. Over the past month, the estimate has changed -2%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, C3.ai is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of C3.ai, the consensus sales estimate of $53.18 million for the current quarter points to a year-over-year change of -29.2%. The $222.61 million and $245.7 million estimates for the current and next fiscal years indicate changes of -11.1% and +10.4%, respectively.
Last Reported Results and Surprise HistoryC3.ai reported revenues of $52.38 million in the last reported quarter, representing a year-over-year change of -25.4%. EPS of -$0.2 for the same period compares with -$0.37 a year ago.
Compared to the Zacks Consensus Estimate of $51.46 million, the reported revenues represent a surprise of +1.79%. The EPS surprise was +23.08%.
Over the last four quarters, C3.ai surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
C3.ai is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about C3.ai. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Everpure P has remained stable following the announcement last Friday that it will join the S&P 500 before the market opens on September 21. This addition highlights a significant achievement for the company, which has seen its revenue growth accelerate for eight consecutive quarters. This growth is driven by strong enterprise demand, increased market share, and the rising adoption of its Storage-as-a-Service offerings, with artificial intelligence (AI) and hyperscale solutions providing further opportunities.
S&P 500 Inclusion: Everpure will transition from the S&P MidCap 400, replacing The Trade Desk TTD in the S&P 500. This move is expected to trigger automatic buying from index-tracking funds and adds to a robust year for Everpure, with its stock rising nearly 50% year-to-date. Company Overview: Everpure offers a comprehensive storage and data management platform centered on flash technology. Their range of products includes traditional enterprise storage and high-performance AI workloads, all built on a unified software architecture designed for enhanced performance, density, reliability, and power efficiency. The company has also ventured into consumption-based storage with its Evergreen//One service, achieving an annualized total contract value (TCV) run rate exceeding $1 billion. Q2 Performance: In Q2 (July), Everpure surpassed expectations with a 37.7% year-over-year revenue increase to $1.19 billion and a 77% rise in adjusted operating income to $230 million. The company has raised its FY27 guidance, now anticipating revenue between $5.03 billion and $5.07 billion, up from a previous range of $4.41 billion to $4.51 billion, and adjusted operating income of $940 million to $960 million. Remaining performance obligations (RPO) grew 44% year-over-year to over $4.1 billion, ensuring strong future revenue visibility. The adjusted gross margin stood at 69.9%, with P strategically maintaining product gross margins at the lower end of its 65-70% range to focus on growth and market share amidst rising component costs. Growth Drivers: The Q2 growth was bolstered by increased pricing, a transition to higher-performance configurations, and enhanced capacity per system, which compensated for lower system volumes. The demand was widespread across all products, regions, and customer segments, with large enterprise interest remaining robust despite significant price hikes. AI Impact: The demand for Everpure's storage solutions is being further fueled by AI as customers develop more data-intensive infrastructures. The company is also expanding its partnerships with hyperscalers, recently securing a contract with a second top-five hyperscaler, which is expected to ramp up significantly in FY28. Everpure anticipates that its hyperscale business will make a more substantial contribution in the latter half of FY27. Everpure's inclusion in the S&P 500 signifies a pivotal moment for a company that is increasingly benefiting from the growing demands of AI and infrastructure modernization. The stock has performed well, driven by rising core enterprise demand, the adoption of Storage-as-a-Service, and emerging hyperscale opportunities. Although shares experienced a pullback after P's impressive Q2 results in late August—likely due to high expectations and concerns over short-term cash flow and product margins—these factors reflect strategic decisions to secure supply and prioritize growth. Everpure still anticipates positive free cash flow for FY27. The significant revision to its second-half outlook indicates resilient demand despite price increases, reinforcing confidence in its growth trajectory. The upcoming Financial Analyst Meeting on September 23 will provide further insights into the company's long-term strategy and financial outlook.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Disclosures I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.
Artificial intelligence (AI) has created trillions of dollars' worth of value for some of America's largest organizations over the last few years, but not every company in this booming industry has been a winner. C3.ai (AI +0.48%) stock, for instance, is down 22% in 2026 (as of the market close last Friday, Sept. 4), as investors abandon ship over the company's declining revenue and steep losses.
Last September, C3.ai's founder, Thomas Siebel, stepped down from his role as CEO to focus on his health issues. Since he played a central role in the sales and customer relationship management processes, his departure led to a sharp decline in the company's revenue.
Fortunately, Siebel returned to lead C3.ai in May, and he is determined to get things back on track. Is it time for investors to start buying the stock?
Image source: Getty Images.
A shift from AI applications to critical AI platforms Developing AI software applications from scratch can be extremely expensive, and it requires specialized technical expertise. Not every business has those resources, so they rely on service providers like C3.ai that can deliver turnkey solutions. But C3.ai's business model is changing -- it still has a portfolio of ready-made AI apps, but it's also becoming a platform provider.
The company launched the C3 Agentic AI Platform late last year, which is effectively an intelligent operating system for businesses. It gains a deep understanding of every existing entity, process, relationship, and piece of data within the enterprise, facilitating the creation of powerful agents that can automate tasks and make key operational decisions (with human permission).
One of the newest tools on the C3 Agentic AI Platform is C3 Code, an advanced programming tool that can build software based on instructions provided in plain English. In other words, it gives enterprises the ability to build their own applications at a lightning-fast pace, even if they don't have a team of world-class engineers.
C3.ai's pivot to become a platform provider is very important, because enterprise AI requires a unified whole-of-business approach. Deploying just one application isn't enough for the average enterprise to stay ahead of their competitors anymore; AI needs to be at the core of every process to maximize productivity and value.
Premium Feature
Moneyball Superscore
38/100
Today's Change
(
0.48
%) $
0.05
Current Price
$
10.51
C3.ai expects sales to sink further C3.ai generated $250.3 million in total revenue during its 2026 fiscal year (ended April 30), a 35% decline from the previous year. The company then generated $52.4 million in revenue during its fiscal 2027 first quarter (ended July 31), a 25% year-over-year decline.
These poor results were a direct consequence Siebel's brief departure, but now that he is back on board, C3.ai's performance is expected to improve. Management's latest forecast suggests the company could deliver up to $240 million in revenue during fiscal 2027 overall, representing a much narrower year-over-year decline of 4% from fiscal 2026. Moreover, Siebel believes a return to sales growth could happen within the next two quarters.
C3.ai has completely restructured its sales department and dramatically cut costs to support its turnaround, which were necessary steps to keep its bottom line in check after its net loss soared by 63% to $470.3 million during fiscal 2026. The company still lost $92.8 million during the fiscal 2027 first quarter, but that was a 20% reduction from the year-ago result.
Plus, C3.ai was modestly free cash-flow positive to the tune of $2.1 million during the first quarter, so the bottom line is certainly trending in the right direction.
A beaten-down stock isn't necessarily a cheap stock C3.ai stock currently trades at a price-to-sales (P/S) ratio of 6.5, which is a discount to its five-year average of 9.4. However, because the company's revenue is forecast to shrink during fiscal 2027, its forward P/S ratio is actually higher than its trailing P/S ratio.
AI PS Ratio data by YCharts
In other words, C3.ai is more expensive when valued against its future financial results than it is today, which is precisely why investors typically avoid buying into shrinking businesses -- they tend to destroy shareholder value over time. However, since Siebel believes C3.ai will return to sales growth on a quarterly basis soon, this particular case might be an exception.
During the first quarter, the company experienced a 73% quarter-over-quarter increase in its gross bookings, which usually represent the value of signed contracts for services that will be delivered in the future. Bookings are often a useful predictor of revenue, so Siebel's optimism might be warranted.
With that said, it might be a good idea for investors to wait until C3.ai's sales actually return to growth before buying its stock, in order to minimize potential risks.
